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Abstract
Human cells are dynamic: they grow, replicate their genetic information (DNA), and divide. Clonal
populations of cells can display marked heterogeneity in size, leading to significant variability in the ratio of
DNA to cellular volume. Despite this variability, cells must maintain a constant concentration of RNA and
protein, produced from DNA, to ensure proper functionality. How do larger cells produce more output from
the same amount of DNA? How do cells that have replicated their DNA prior to cellular division produce the
same output as before? Using RNA fluorescence in situ hybridization (RNA FISH), we visualize and count
individual RNA molecules in single cells, allowing for precise quantification of transcriptional output of single
genes. We also use single-cell RNA sequencing to quantify transcriptional output from all ~20,000 genes
encoded in the genome simultaneously. Surprisingly, we discovered that the cell implements two separate
transcriptional mechanisms to compensate for changes in cell size and DNA content. Through cell-fusion
experiments, we show that a diffusible trans factor, which we believe may be RNA polymerase II, increases
transcriptional burst size in larger cells, compensating for changes in volume. Meanwhile, a DNA-linked cis-
acting factor reduces the frequency of transcription per gene copy by a factor of two upon DNA replication,
allowing the cell to still produce the same amount of RNA after replication, despite having twice the number
of DNA copies. We show that transcription depends strongly on volume, and we therefore present a new
"noise measure" which provides a measure of gene expression variability that takes volume into account. We
perform single-cell RNA sequencing to measure noise genome-wide, and find that cell-type-specific genes
tend to exhibit more expression noise than genes that are ubiquitously expressed across cell types. Finally, we
have uncovered a fundamental mechanism by which cells are able to functionally compensate for naturally-
occurring variability in size and DNA copy number.
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ABSTRACT
SINGLE HUMAN CELLS USE TRANSCRIPTIONAL MECHANISMS TO
COMPENSATE FOR DIFFERENCES IN CELL SIZE AND DNA CONTENT
Olivia M. Padovan-Merhar
Arjun Raj
Human cells are dynamic: they grow, replicate their genetic information (DNA), and
divide. Clonal populations of cells can display marked heterogeneity in size, leading to
significant variability in the ratio of DNA to cellular volume. Despite this variability,
cells must maintain a constant concentration of RNA and protein, produced from DNA,
to ensure proper functionality. How do larger cells produce more output from the same
amount of DNA? How do cells that have replicated their DNA prior to cellular division
produce the same output as before? Using RNA fluorescence in situ hybridization
(RNA FISH), we visualize and count individual RNA molecules in single cells, allowing
for precise quantification of transcriptional output of single genes. We also use single-cell
RNA sequencing to quantify transcriptional output from all (∼20,000) genes encoded
in the genome simultaneously. Surprisingly, we discovered that the cell implements two
separate transcriptional mechanisms to compensate for changes in cell size and DNA
content. Through cell-fusion experiments, we show that a diffusible trans factor, which
we believe may be RNA polymerase II, increases transcriptional burst size in larger
cells, compensating for changes in volume. Meanwhile, a DNA-linked cis-acting factor
reduces the frequency of transcription per gene copy by a factor of two upon DNA
replication, allowing the cell to still produce the same amount of RNA after replication,
despite having twice the number of DNA copies. We show that transcription depends
strongly on volume, and we therefore present a new “noise measure” which provides a
measure of gene expression variability that takes volume into account. We perform
v
single-cell RNA sequencing to measure noise genome-wide, and find that cell-type-
specific genes tend to exhibit more expression noise than genes that are ubiquitously
expressed across cell types. Finally, we have uncovered a fundamental mechanism by
which cells are able to functionally compensate for naturally-occurring variability in
size and DNA copy number.
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Chapter 1
Introduction
The human body harbors over 200 different types of cells, each of which has an
individual, specialized function. Accordingly, there is a range of human cell sizes that
spans many orders of magnitude. Interestingly, even cells of the same type can show
large size variability both in vivo and when grown in culture [7, 11, 67]. Despite
this large variability in volume, we assume that clonal populations of cells in culture
maintain similar functionality, suggesting that something must be constant between
these cells, even if volume is not. The rates of biochemical reactions within a cell
depend on the concentrations of reactants and enzymes, suggesting that in order for
large and small cells to function similarly, the concentrations of biomolecules within
the cells must remain constant, and hence the absolute numbers of molecules would
have to scale roughly linearly with cellular volume (see Marguerat et al. for an excellent
review [34]). How does the cell tackle this problem?
1.1 Gene expression and cellular volume
Yeast, bacteria, and many plants display a striking correlation between cell (or
organism) size and the number of copies of DNA within each cell [38, 40, 52, 66]. Yeast
double in size after DNA replication as they progress from the G1 to G2 phases of the
cell cycle [80], and haploid species of yeast are, on average, half the size of their diploid
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counterparts [75]. Many agricultural crops that are grown for their size and grain
output have higher ploidy than the same plants grown in the wild [10, 44, 52, 72]. Yet
mammalian cells do not always follow this trend. Surprisingly, DNA is the one molecule
in mammalian cells that need not scale with cell size, either within a population of
clonal cells, or between cell types of different sizes and functions. While human cells
are, on average, larger in G2 than G1, volumes in all stages of the cell cycle are highly
variable. In most mammalian cells, DNA will typically exist in two or four copies per
cell, and even cells with the same number of DNA molecules can differ widely in size
[7, 67, 78]; as such, DNA concentration can vary dramatically from cell to cell. This
poses a challenge for cellular homeostasis, for if two otherwise identical cells with the
same DNA content had different volumes, then the larger cell must somehow maintain
a higher number of biomolecules with that same amount of DNA.
Biologists have been curious about this puzzle for decades, beginning in the 1970s
with papers from Crissman and Steinkamp [11] and Fraser and Nurse [19]. Crissman and
Steinkamp performed a primarily observational study, where they used flow cytometry
to measure cellular volume and total protein content simultaneously in populations of
human cells. They found that the distribution of ratios of protein-to-volume was much
tighter than either the DNA-to-volume or DNA-to-protein ratios, giving us our first
hint that (1) cells display a variety of volumes even when grown in culture, and (2) cells
employ some mechanism to maintain protein at a constant concentration, regardless of
cell size. In 1979, Fraser and Nurse began to unravel the transcriptional underpinnings
of the scaling of cellular components with volume, using yeast as a model organism.
They measured RNA concentration (RNA/volume) for three strains that had different
“gene concentrations” (DNA/volume ratios), and found that, despite a 2-fold change
in gene concentration between the largest and smallest strain, the change in mRNA
concentration was negligible. They concluded that the cell must have a compensatory
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transcriptional mechanism in place to maintain a constant concentration of RNA
despite changes in gene concentration, and provided evidence that smaller cells produce
less RNA by delaying an increase in transcription until late in G2. Even with the
relatively limited techniques available nearly 40 years ago, biologists were able to
detect this scaling mismatch between DNA and volume and begin to understand how
cells are able to compensate for it through transcription. However, these measurements
were primarily observational and were either performed on bulk populations of cells or
were relatively qualitative. These studies began to define the problem—how can some
cells produce more RNA from the same amount of DNA?—but they were not able to
definitively answer that question.
It was not until relatively recently that the advent of RNA sequencing, single-
molecule imaging, and other technological developments made it possible to gain
new understanding of transcriptional regulation and its relationship to cell size. A
number of recent studies have shown that both the amount of RNA and protein
generally scales with cellular volume [34, 35, 55, 71, 79] and ploidy [75], with some
further finding that transcription itself changes in mutants with larger or smaller cell
volumes [19, 55, 79]. Most of these studies were performed in yeast, with a few notable
exceptions [39, 55, 71].
Schmidt and Schibler [55] played a major role in establishing this field by defining
“cell size regulation”, or the mechanism by which cells of different sizes are able to
produce different amounts of RNA from the same amount of DNA. They observed
that cells in different human tissues had different DNA/cytoplasm ratios and that
total RNA scaled with cytoplasmic size, not DNA content. For the first time in human
cells, they showed that transcription rate, not degradation rate, scaled with cell size.
However, they studied transcriptional differences between cell types, and were therefore
unable to make a claim about how cells from a single lineage compensate for natural
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variability in volume.
Miettinen and colleagues [39] used a clever method to examine cells of different
sizes within the same tissue, by studying regenerated mouse liver tissue with and
without a particular gene knockout. Wild-type livers regenerated by producing many
new cells, while knockout livers regenerated by increasing the size of existing cells,
providing the researchers with large and small liver cells to examine. They performed
RNA sequencing on these large and small cells to identify differentially expressed genes,
but found that most genes were not differentially expressed when they normalized
to the total number of reads. We note here that by normalizing to the total number
of reads, one is essentially normalizing away any volume effects and will not observe
any global changes in expression between conditions. Therefore it is likely that the
majority of genes in the genome were in fact expressed at higher global levels in the
larger cells, but all genes were upregulated by the same amount. This finding lends
further credence to our emerging hypothesis that there exists a global control that can
change expression levels of all genes in a concordant manner to scale with cell size.
In another interesting work, Watanabe and colleagues [71] discovered a small
C. elegans mutant that contained the same number of cells as the larger wild-type
worm, and showed that the total protein content of worms from both strains was
approximately proportional to organism size. All three of these studies further show
that there is a scaling of RNA and protein with volume within multicellular eukaryotic
organisms. However, these studies also demonstrate the difficulty of making significant
progress on this mechanistic question in higher eukaryotes, due both to the difficulty
of performing perturbative experiments in such cells, and the challenges associated
with studying single cells as opposed to bulk populations.
On the other hand, there are a few very interesting mechanistic papers on this
subject in yeast. Wu and colleagues [75] compared large tetraploid yeast cells to mutant
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haploid cells of the same size, and found that their gene expression profiles were similar.
Furthermore, they found that gene expression increased with cell size by examining
haploid mutants of different sizes. These results imply that cells have a mechanism
allowing gene expression to scale with volume, independent of DNA content. Zhurinsky
and colleagues [79] took this a step further, generating cells that spanned a five-fold
range of DNA/protein ratios. Within a certain “biological” window, they found the
same results as Wu et al., namely that gene expression scaled with volume. However,
they pushed the limits of the DNA/protein ratio, finding that in very large cells, DNA
content became limiting and they observed a plateau in expression levels. Moreover,
they examined levels of individual transcripts, and found that for all cells, nearly all
genes were expressed at similar relative levels in all conditions, again demonstrating
the existence of a global transcriptional regulator. This is the first piece of literature
to concretely begin to define a “limiting factor” linking cell volume to transcription.
All of the above experiments have been extremely influential in defining this field
and addressing key problems, however, there are still many unanswered questions.
For example, studying different tissue types or using mutants does not allow one
to establish a causal relationship between cellular volume changes and transcript
abundance. Such a relationship would have strong implications for the interpretation
of gene expression measurements because if cellular volume changes can in and of
themselves change global expression levels, observations of changes in global expression
levels in response to various perturbations may actually be the indirect consequence
of changes to cellular volume rather than resulting from direct global transcriptional
responses to the perturbations per se. Further, while these experiments have hinted at
the existence of a limiting factor linking transcription and volume, it has not been
fully characterized. Nor do we understand exactly how transcription is modulated in
cells of different sizes, or how cells compensate for changes in DNA in addition to
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volume.
1.2 Stochastic gene expression
All of the literature we have discussed so far points to the existence of a mechanism
allowing cells to compensate for changes in volume and DNA content in order to
maintain a constant concentration of RNA and protein, ostensibly within both bulk
populations and single cells. Yet there exists an enormous body of work suggesting that
transcription is inherently stochastic, and that RNA and protein levels vary widely at
the single-cell level [50, 51, 54]. We will discuss this literature and see if it is possible
to reconcile these seemingly contradictory findings.
On the face of it, transcription must be random to some extent. To simply initi-
ate transcription, a whole host of transcription factors and cofactors must, through
stochastic diffusion, arrive at an accessible promoter and assemble into a transcription
initiation complex. In principle, there are two ways in which transcription can proceed.
One possibility is that “active” genes are constitutively “ON”, and the rate-limiting
step of transcription is the time it takes for all of the correct elements to arrive at
the promoter. This would cause RNA to be produced in a stochastic manner, but
with a uniform probability per unit time to produce a single molecule of RNA. Such
production would lead to a Poisson distribution of RNA in single cells. However,
significant evidence in bacteria, yeast, and higher eukaryotes suggests that RNA pro-
duction is better approximated by a two-state model [28], in which the promoter
switches stochastically between “ON” and “OFF” states. In this model, multiple RNA
molecules are produced in short bursts during the “ON” state, leading to a much
broader distribution in RNA counts than in the Poisson case. This is referred to as
“bursty transcription”.
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A few key papers demonstrated the existence of bursty transcription in bacteria
and eukaryotes. Some studies used a live reporter assay to observe transcription in
real time, while others were able to infer dynamics through analysis of static RNA
distributions in fixed cells. Live-cell RNA imaging is primarily done through the
use of the MS2 reporter assay, in which two constructs are introduced into a cell:
a gene of interest attached to a cassette of MS2 binding sites, and a gene encoding
the MS2 protein fused to a fluorescent protein. By counting instances (or summing
total fluorescence intensity) of the reporter fluorescence, one can read out the total
amount of the RNA of interest in the cell. Golding and colleagues [20] used this
method to observe transcription of a fluorescent protein transgene in E. coli. They
observed that transcription occurred in bursts, and that the gene appeared to fluctuate
between an “ON” and an “OFF” state, providing some of the first live-cell evidence
for transcriptional bursting. Chubb and colleagues [8] used a similar methodology
to observe transcription of an endogenous gene in Dictyostelium. By using targeted
integration, they inserted a cassette of MS2 binding sites directly into a gene, and
used a fluorescently-tagged MS2 protein to read out transcriptional activity. They
found that transcription of this endogenous gene was also pulsatile, showing for the
first time that endogenous loci—not just transgenes—exhibit bursty transcription in
eukaryotes.
More recently, Suter and colleagues [59] engineered a system to study transcriptional
dynamics in live mammalian cells. They inserted the coding sequence for a short-lived
luciferase protein (encoded by a short-lived RNA) downstream of either endogenous
or synthetic promoters. They argued that because the reporter and its RNA are
both short-lived, readout from the reporter should be indicative of transcriptional
dynamics. For all types of promoters used, the authors found that transcription
was bursty. These reports provide undeniable evidence that transcription occurs in
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bursts, be it in bacteria, single-celled eukaryotes, or mammals. However, most of these
studies suffer from a significant drawback, namely that most of these observations are
performed for transgenes, which are likely not subject to the same sorts of regulation
as endogenous genes. The one study that did observe transcription of an endogenous
gene [8] did not use an easily-scalable technique, therefore making it difficult to study
multiple genes and draw any broad conclusions about transcription in general. To
fully understand transcriptional regulation as it occurs naturally, we need to be able
to study transcriptional output from an unperturbed gene locus. We are interested in
discovering whether the transcriptional patterns of endogenous genes are coordinated
in such a way to allow RNA and protein to scale with cellular volume.
RNA fluorescence in situ hybridization (RNA FISH) is a technique that allows
one to visualize individual RNA molecules in single cells using a fluorescent tag
by exploiting the complementarity of single-stranded RNA and DNA [18]. Raj and
colleagues [47] used this technique to label both transgenes and endogenous genes
in mammalian cells. The authors designed a single-stranded DNA oligonucleotide to
be complementary to a repetitive region of their gene of interest, and labeled each
oligonucleotide with a single fluorophore. Because multiple oligonucleotide probes
bound to the repeat region, the signal from that transcript appeared as a bright
spot in the microscope, considerably brighter than any background signal caused
by off-target oligonucleotide binding. This technique was performed in fixed cells,
so it was impossible for the authors to visualize transcriptional bursting over time.
However, they used an alternative method to study bursting, noting that sites of
active transcription in the nucleus were characterized by bright accumulations of
oligonucleotide probe. They were therefore able to identify sites of active transcription
in the nucleus and record the size and frequency of these transcriptional bursts. They
found that both their transgene and the RNA polymerase II gene exhibited bursty
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transcription, marked by infrequent, but bright, sites of active transcription. Using the
RNA FISH technique, the authors were able to not only observe sites of transcription,
but also count the number of single molecules of RNA in each cell. They observed
highly variable numbers of RNA molecules from cell to cell, both of the transgene and
even the gene encoding a subunit of RNA polymerase. Zenklusen et al. [77] used a
similar technique in yeast to show that, interestingly, endogenous genes can exhibit
either bursty or Poissonian transcription.
More recently, Raj and colleagues expanded this technique to label any endogenous
gene, by designing multiple individually-labeled oligonucleotides that each target a
sequence on the gene of interest [49]. By designing ∼30 probes for a single transcript,
they were able to achieve similarly high signal-to-noise ratios as they were when
targeting a repeat region. Many groups have independently used this technique to
show that endogenous genes display bursty transcription and that RNA abundance is
highly variable from cell to cell in a population [58, 65]. This version of RNA FISH is
the technique we use to measure gene expression in this thesis.
We have now seen a large body of evidence suggesting that not only is gene
expression bursty in both prokaryotes and eukaryotes, but also that gene expression
appears to be variable between cells. The implications of this variability for cellular
homeostasis are still unclear. It is important to note that in the studies listed above,
the authors were primarily comparing the absolute amount of RNAs or proteins
between cells, without taking cell size into account. If RNA is expressed at a constant
concentration, however, we would not necessarily expect the absolute amount to remain
constant from cell to cell. It is possible that most of the observed variability is in
fact due to the scaling of RNA production with volume. Furthermore, there is some
evidence, detailed nicely in this review [34], that suggests that transcription kinetics
may be modulated globally, perhaps by an extrinsic factor such as cellular volume.
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If it is true that transcription and RNA number scales with volume at the single cell
level, it will be necessary to revisit our understanding of stochastic gene expression and
cell-to-cell heterogeneity. That said, there are some extreme examples of differences in
gene expression between cells [47] which likely cannot be explained simply by volume.
We must better understand the range of variability in gene expression and determine
how, or even whether, gene expression scales with cellular volume. We have argued
that, in order for cells to maintain homeostasis, they must express RNA—especially
RNA from “housekeeping” genes and other genes important for cells to function
properly—in concordance with volume to some extent. However, it remains to be seen
how many genes express RNA in such a manner.
1.3 Modeling gene expression
If gene expression does depend strongly on cellular volume, then it will be necessary
to revisit our models of gene expression “noise”, which heretofore have been primarily
based on variability in RNA number between cells.
The standard model of gene expression is based on the “random telegraph model”
[45]. In this model, genes stochastically fluctuate between ON and OFF states. Genes
can only be transcribed when the gene is ON, resulting in random bursts of transcription.
According to the random telegraph model, the gene switches between ON and OFF
states at exponentially distributed intervals and transcription is assumed to be a
Poisson process when the gene is ON. In terms of reactions, the model is as follows:
I
kon→ A
A
koff→ I
10
A
µ→ A+M
M
δ→ 0,
where I indicates an inactive gene, A indicates an active gene, and M is mRNA. The
model as it stands does not take volume, or any other extrinsic source of variability,
into account. If overall RNA abundance does, in fact, scale with volume, then at least
one of the rates, likely either the transcription rate µ or the degradation rate δ, would
need to scale with volume. We discuss this modified model further in Chapter 4.
1.4 Overview
In the first half of this thesis, we use single molecule RNA imaging and compu-
tational image analysis to measure transcript abundance and cellular volume simul-
taneously in individual human cells, showing that, for many genes, RNA abundance
does scale with volume. We show that this scaling is due to increased transcription,
not reduced degradation, in larger cells. We use cell fusion experiments to show that
cellular size can directly influence gene expression via a global transcriptional control,
and it does so through modulation of transcriptional burst size. Furthermore, quanti-
tative analysis of these experiments reveal that the mechanism underlying this global
regulation does not merely sense cellular volume, but rather integrates both DNA
content and cellular volume to produce the appropriate amount of RNA for a cell of a
given size. We also show that a separate mechanism exists to reduce the frequency
of transcription immediately upon DNA replication, which prevents early-replicating
genes from producing an excess of RNA during early S phase.
The observation that RNA expression scales with cellular volume led us to reconsider
the traditional measures of “noise” in gene expression. In collaboration with our
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colleague Abhyudai Singh, we developed a quantitative framework for interpreting
gene expression variability in single human cells, which we discuss in Chapter 4. We
show that many genes that would traditionally be considered noisy actually display
noise levels close to Poisson when volume dependence is taken into account. To further
extend this noise analysis, we performed single-cell RNA sequencing and calculated
noise measures genome wide, revealing that cell-type specific genes are more variable
than ubiquitously expressed genes.
Some of the work presented here has appeared in print in the following publications
and has been reprinted with permission:
• O. Padovan-Merhar et al., Molecular Cell (Set for publication on April 9, 2015).
• M. N. Cabili et al., Genome Biology 16 20 (2015).
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Chapter 2
What’s really going on here?
Understanding the scaling of
biomolecules with cellular volume
2.1 We measure mRNA counts and volume in sin-
gle cells using RNA FISH
We first looked at the number of mRNA molecules in individual primary fibroblast
cells (human primary foreskin fibroblasts, CRL2097) within a population to see whether
mRNA counts scale with cellular volume at the single cell level. We measured both
mRNA abundance and volume simultaneously using single molecule multi-color mRNA
fluorescence in situ hybridization (RNA FISH [18, 49]), which allowed us to detect
the positions of individual mRNAs in three dimensions as fluorescent spots in the
microscope (Fig. 2.1).
With the filter sets on our microscope, we can detect up to six colors simultaneously.
For most experiments, we labeled (1) the mRNA from our gene of interest, (2) the
introns from our gene of interest, which allows us to accurately detect sites of active
transcription, (3) GAPDH mRNA, which is highly expressed and allows us to calculate
13
87 mRNA
52 mRNA
TBCB mRNA
6.
25
 µ
m
88 µm
B
C
Target mRNA
A
Figure 2.1: Representative RNA FISH image and volume measurement. (A) Schematic
of RNA FISH technique. We designed 20-base oligonucleotide DNA probes with
sequences complimentary to our target mRNA. We designed ∼30 probes, each labeled
with an individual fluorophore, to tag a single species of mRNA, giving us a high
signal-to-noise ratio. (B) Single molecule RNA FISH. DAPI stain in blue, TBCB
mRNA FISH probe in white. Scale bar is 10µm. (C) Representative outline of a
primary fibroblast cell found using our volume calculation algorithm.
14
the 3D boundaries and volume of the cell, (4) CCNA2 mRNA, a cell cycle marker, (5)
actin protein, which allows us to accurately visualize the boundaries of the cell in 2D,
and (6) DNA with DAPI to visualize the nucleus.
We measured mRNA abundance and volume in single primary fibroblast cells for
30 different genes, calculating volume as described in the Methods (Appendix A).
Briefly, we detected the 3D locations of all GAPDH mRNA molecules in the cell, which
fill the volume of the cell. We computationally identified the outermost molecules
and interpolated those points to define the top and bottom boundaries of the cell,
and we calculated volume by summing the height difference between top and bottom.
Note that this method will systematically underestimate the volume of the cell, so
we use a statistical algorithm to correct for bias in volume measurement. We show a
representative RNA FISH image and cellular volume schematic in Fig. 2.1. Note that
the fibroblast cells are adherent and have a characteristic “fried egg” shape, making it
difficult to estimate volume in any way other than actually determining the boundaries
through RNA FISH. We repeated these measurements for 25 genes in a lung cancer
cell line (A549) and for 19 genes in growth-arrested fibroblast cells (see Appendix B).
The cell volumes we measured varied over an approximately six-fold range, ranging
on average from 1 to 6 picoliters (pL), although the largest fibroblast we measured had
a volume of 8.95pL, and the smallest had a volume of 0.443pL. These measurements
agree with measures of mammalian cellular volume obtained using different methods.
Bryan et al. [7] measured volumes of lung cancer cells using both a Coulter counter
and a microfluidic device, a “suspended microchannel resonator”, and found that
these cells had a mean volume of ∼3pL, with a range from 1-7pL. Tzur et al. [67]
measured volumes of mouse lymphoblasts using a Coulter counter, and found the
cells to have volumes of ∼1.5pL, ranging from ∼0.5-3pL. Zhao et al. [78] estimated
HeLa cell volumes to be approximately 2.6pL by assuming them to be spherical and
15
extrapolating from their diameter as viewed in a light microscope. Our measurements
of cell volume have a similar mean and variance to those reported in these studies, so
we believe our method of calculating volume is accurate.
To test that our measurement was not biased by our choice of guide gene, we calcu-
lated volume using both GAPDH (RNA count = 2762±156.7, volume = 2438±170.3pL)
and EEF2 (RNA count = 1063±63.51, volume = 2147±160.2pL), finding that both
methods yielded similar results (Fig. 2.2). We also calculated volume by randomly
selecting only half the number of GAPDH mRNA spots, and found that volume was
the same before and after reducing the number of spots (Fig. 2.2). Thus we have
shown that our volume calculation is robust to fluctuations in the total number of
GAPDH mRNA and that our metric is not biased by our choice of guide gene.
All of our measurements were taken in fixed cells, which had been treated with
formaldehyde to cross-link and preserve distances between all molecules within the cell.
It is possible that the fixation procedure could systematically change cellular volume,
so we therefore calculated “volume” as best we could throughout the fixation process.
We introduced fluorescent beads to the media of live cells, and allowed the beads to
settle onto the tops of the cells. We then imaged the cells in 3D, identifying the top
of the cells by the location of the beads, and the area of the cells through brightfield
images. Without removing the cells from the microscope, we added formaldehyde to the
cells and allowed them to “fix” as usual. After fixation, we repeated the measurement
with the fluorescent beads. We finally added ethanol to permeabilize the cells, and
repeated the measurement a final time. Heights and areas of the cells are shown in
(Fig. 2.2), and qualitatively agree with the measurements of volume that we calculate
through our RNA FISH method. Further, the measurements for each cell did not
change significantly or systematically throughout the fixation and permeabilization
procedure, so we have shown that there are no large biases in volume measurements
16
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Figure 2.2: Volume calculation controls. (A) and (B) We monitored cells on the
microscope throughout the process of fixation. We took measurements of the same
cells live, after fixing in 4% formaldehyde for 10 minutes, and after permeabilizing in
70% ethanol for 30 minutes. (A) We measured the areas of the cells through brightfield
images. (B) We measured the height of the cells by coating the cells with fluorescent
beads. (C) To demonstrate the robustness of the volume calculation algorithm, we
calculated volume for the same cells using all the GAPDH mRNA spot coordinates
as detected by RNA FISH, or using only half of the points, chosen randomly. (D)
We calculated volume using a different gene, EEF2. Black lines indicate a fit with
intercept = 0 and slope = 1.
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that arise from fixation. We also note that all cells behaved similarly during this
process, so fixation does not lead to random variability in volume between cells.
2.2 mRNA counts scale with cellular volume in
single mammalian cells
We measured RNA and volume in single cells using the methods described above.
For most genes, mRNA counts and volumes in single cells exhibited a strongly positive,
linear correlation (we show data from a few representative genes in Fig. 2.3), although
mRNA from many genes—primarily transcription factors and other “non-housekeeping”
genes—displayed less of a correlation, which we discuss further in Chapter 4. See
Appendix B for all genes examined. Because in general larger cells had proportionally
more transcripts than smaller cells, the mRNA concentration remained relatively
constant from cell to cell despite considerable variation in absolute mRNA numbers.
This scaling property was not confined to high abundance mRNAs like GAPDH and
EEF2 —genes expressing as few as 10-20 mRNA per cell such as ZNF444 and KDM5A
scaled similarly. We also measured rRNA, by far the most abundant RNA in the cell.
rRNA is so abundant that it is impossible to resolve individual molecules by RNA
FISH, so we instead summed the total intensity of the RNA FISH signal. We found
that this quantity scaled with cellular volume as well (Fig. 2.4), suggesting that RNA
products from both RNA polymerase I (rRNA) and II (mRNA) display similar scaling
properties. We also observed the same behavior for short lived mRNA such as UBC
and IER2, whose half-lives are 2.9 and 2.2 hours, respectively [62]. These results show
that this scaling property is universal, and not simply limited to highly abundant or
long-lived transcripts.
It is possible that the question of how RNA scales with volume is simply answered
18
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●●
●●
●
●
●●
●●
●
●
●●
●● ●
●●
●
●
●
● ●●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
● ●●
●
●
●
●●● ●
●● ●●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
● ●
●
●●●
● ●
●●
●
●
0
500
1000
1500
2000
0 1 2 3 4 5
Volume (picoliters)
C
yt
op
la
sm
ic
 R
N
A
EEF2
r=0.85
LMNA
r=0.70
TBCB
r=0.73
Figure 2.3: RNA count scales with volume for many genes. mRNA vs. volume for
EEF2, LMNA, TBCB. Each point represents one single cell measurement. Each data
set is a combination of at least two biological replicates, with at least 30 cells per
replicate. Dashed lines represent best fit via linear regression.
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Figure 2.4: Ribosomal RNA. (A) We measured ribosomal RNA by quantifying total
fluorescence intensity in the cytoplasm from an rRNA FISH probe in cycling fibroblast
cells. (B) We measured the rRNA internally transcribed spacer (ITS, the rRNA
“intron”) by quantifying total fluorescence intensity in the nucleus from an ITS RNA
FISH probe.
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Figure 2.5: Cell cycle determination. (A) We simultaneously measured CCNA2 and
HIST1H4E mRNA by RNA FISH to precisely determine cell cycle position. Each
data point is a single cell measurement. Data shown are from one of four biological
replicates. (B) Volume distributions in G1 and G2. We determined cell cycle position
using CCNA2. n = 841 cells in G1, 191 cells in G2.
by considering cell cycle progression. As a cell progresses through the cell cycle, it
grows (theoretically doubling in size) and also replicates its DNA. One might expect
that the larger cells we observe are simply further along in the cell cycle and have
already replicated their DNA. In this scenario, larger cells have twice the number of
DNA molecules as compared to smaller cells, and therefore can produce more RNA.
To address this possibility, we co-stained cells with cell cycle markers [17, 29, 53, 73] to
differentiate between G1, S, and G2 phases. Cyclin A2 (CCNA2 ) mRNA is expressed
only in S and G2 phases, while Histone 1, H4e (HIST1H4E ) mRNA is expressed
only in S phase. We classified cells as being in G1 if both CCNA2 and HIST1H4E
mRNA levels were low (cutoff = 20 CCNA2 mRNA), S if CCNA2 was mid-range and
HIST1H4E was high, and G2 if CCNA2 was high and HIST1H4E was low (cutoff =
230 CCNA2 mRNA) (Fig. 2.5).
Interestingly, cell volume varied as much for cells in individual phases of the cell
cycle as the population overall, with a shift in the distribution towards G2 cells being
20
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Figure 2.6: GAPDH RNA scales with volume similarly throughout the cell cycle.
Marginal histograms show volume and mRNA distributions. Colors indicate cell cycle
stage determined by Cyclin A2 (CCNA2 ) mRNA count. Dashed diagonal line is the
best linear fit of RNA vs. volume. Vavg indicates the average primary fibroblast volume.
We determined volume-independent and -dependent transcript levels using the linear
fit and Vavg. Data are a 15% subset of 1868 cells spanning >30 biological replicates.
larger, but only by ∼10% (Fig. 2.5). Although it might initially be surprising that
G2 cells are not on average twice as large as G1 cells, we believe this can be explained
by non-uniform growth throughout the cell cycle. If, for an extreme example, cells
remained the same size throughout the cell cycle, only doubling in size immediately
before division, we would not expect a population average of cells to show that cells
in G2 are twice the size of those in G1. The size differences that we observe are likely
due to a less extreme case of non-uniform growth during the cell cycle. Further, we
observed the same linear relationship between mRNA and volume for cells restricted
to a particular phase of the cell cycle as for all cells together (Fig. 2.6), showing that
mRNA count did not depend on DNA content of the cell.
In addition to cellular volume, we also measured nuclear size throughout the cell
cycle. Our imaging techniques did not allow for a 3D nuclear volume measurement,
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Figure 2.7: Nuclear area scales with cell cycle stage and cell size. (A) Nuclear area vs.
cytoplasmic volume. We measured cytoplasmic volume using our standard method.
We measured nuclear area using the DAPI stain. We note that we only measured
nuclear area and not volume. R2 = 0.358. (B) Density plot of nuclear area across cell
cycle stages. n = 1866 cells.
so we approximated nuclear volume by nuclear area, defined by the DAPI stain. We
found that nuclear size increased somewhat with cellular volume, and that nuclear size
increased in later stages of the cell cycle (Fig. 2.7). It is interesting that different cells
in the same stage of the cell cycle display different nuclear sizes. Such cells have the
same number of DNA molecules, so a larger nucleus implies that the same amount of
DNA is taking up more space. This larger nucleus could be the result of more active
transcription, as it is likely that DNA bulges and takes up more space during active
transcription [64]. It could also be the effect of simply having a larger nuclear envelope.
In this case, everything in the nucleus is just less dense. We explore the consequences
of different nuclear sizes in Section 3.3.
It has been shown in yeast and bacteria that cell size scales with ploidy [38, 40, 66].
It could be the case that in our system, larger cells have a higher ploidy, leading to a
larger cell volume and increased RNA abundance. However, we note that the primary
fibroblast cells exhibited normal ploidy [29], so our results are not simply explained
by differences in ploidy between cells. Additionally, the A549 lung cancer cell line is
22
known to have abnormal ploidy, containing more than 2 copies of some genes [23].
Despite the abnormal number of DNA molecules, we still observe that RNA scales with
volume in these cells, demonstrating that cells have a means of maintaining volume
scaling despite differences in DNA content. Together, these results show that ploidy
differences do not change our qualitative observations, and that our results are not
simply due to differences in ploidy among cells.
We next wanted to check whether mRNA scaling is dependent upon continual
cellular growth, or if the scaling continues even in the absence of active growth. We
grew the primary fibroblasts for 7 days in medium lacking serum, making them
quiescent. The cells ceased proliferating and were all arrested in G0, as indicated by
cell cycle markers. Despite growth and cell-cycle arrest, we found that mRNA count
and volume still scaled strongly, showing that neither progression through the cell
cycle nor continual cell growth were required for mRNA count to scale with cellular
volume. Interestingly, we found that both the mean mRNA count and mean volume
decreased in quiescent cells, although the cells maintained a similar concentration of
GAPDH and other mRNA between the two conditions (Fig. 2.8). This finding has an
important implication for single-cell studies. By simply counting mRNA between the
two conditions, we likely would have come to the conclusion that there is a fundamental
difference in activity or cellular function between the two conditions, as the quiescent
cells have less mRNA overall. However, by taking volume into account, we saw that
both conditions actually had the same mRNA concentration and likely had similar
“activity” levels, despite the lack of growth in the quiescent cells. This finding highlights
the importance of including volume as a variable in such single-cell measurements.
It is important to note that while the mRNA abundance is strongly correlated with
cellular volume, the y-intercept (a) of a line fit to the data (mRNA = a+ bV ) was
non-zero, indicating that mRNA count in individual cells had a volume-independent
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Figure 2.8: Comparison of GAPDH RNA expression in cycling and quiescent primary
fibroblast cells. (A) Dashed lines are best fit line for GAPDH in cycling cells. Data
are an 8% subset of 1868 cells spanning >30 biological replicates for cycling cells, and
10% subset of 1105 cells for quiescent. We only analyzed quiescent cells that had fewer
than 20 CCNA2 mRNAs. (B) Mean GAPDH mRNA count and (C) concentration in
different growth conditions for data from (A).
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component in addition to the volume-correlated component (Fig. 2.6). We quantified
for each gene the relative fraction of mRNA that was volume-correlated vs. volume-
independent in a cell of average volume (i.e., a/(a+ bVavg) vs. bVavg/(a+ bVavg)). We
found that different genes displayed a range of values for volume-independent and
volume-correlated abundance (Fig. 2.9), although the volume-dependent fraction
was dominant for most genes examined. Of note, these results show that the mRNA
concentration is actually somewhat greater in smaller cells than in larger ones; for
most genes, the smallest cells had an mRNA concentration 1.2-3 times greater than
that of the largest cells (Appendix B). We later describe a mathematical model
providing a potential explanation for this increased concentration based on nuclear
volume measurements (see Section 3.3).
We compared volume-correlated and -independent fractions in cycling and quiescent
cells to see if there was a link between growth and volume-correlated or -independent
mRNA abundance. Interestingly, although the overall mRNA concentration was similar
between conditions, both volume-correlated and -independent abundance was lower
in quiescent (growth-arrested) cells, although there was a more significant difference
between the two conditions for the volume-independent abundance (Fig. 2.9). This
suggests that there may be a link between volume-independent expression and growth.
Perhaps cells produce mRNA in a volume-independent manner to trigger or continue
growth. Our data is not sufficient to make a substantial claim about this phenomenon,
but it is an interesting hypothesis.
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Figure 2.9: Volume-dependent and volume-correlated RNA abundance in fibroblast
cells. (A) Fraction of volume-independent and -dependent RNA expression from the
linear fit of RNA vs. volume for 21 genes in primary fibroblast cells (we omitted highly
variable genes whose volume-independent fractions were less than zero). Data for
each gene are a combination of at least two biological replicates, with at least 30 cells
per replicate. (B) Concentration of mRNA in cycling and quiescent fibroblast cells.
Each data point represents a single gene. Error bars represent standard error of the
mean. (C) and (D) We compared volume-dependent and -independent abundance for
cycling and quiescent cells. All error bars represent confidence intervals of the slope or
intercept of the fit, normalized to the scale of the plot. We omitted error bars that
extended below zero. Each gene had a minimum of two biological replicates, with at
least 30 cells per replicate. We omitted highly variable genes with intercept terms less
than 0.
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2.3 RNA counts scale with organism size in C. el-
egans
We have shown that mRNA count scales with volume in single cells, and we wanted
to check whether we could observe similar behavior in intact organisms. C. elegans is
a small nematode, and is a model organism touted for its optical transparency and
genetic tractability. Because these worms are transparent we are able to perform RNA
FISH on intact organisms. Thanks to the tractable genetics of C. elegans, we obtained
two previously-generated strains of worm from the Caenorhabditis Genetics Center
that allowed us to look at worms with cells of different sizes. CB502 worms have a
mutation in the gene sma-2, leading to a small body size; N2 worms are wild-type
and have a body size approximately twice that of CB502 (Fig. 2.10). Despite these
differences in size, these two types of worm have the same number of cells. In general,
each cell is simply smaller in CB502 worms, although some of the intestinal cells also
have different ploidy [71].
Each nematode was too large to image completely, so we chose regions of the worm
that were easily identifiable between specimens, namely the head and gonad regions.
We measured both RNA and DNA density in the heads and gonads of adult nematodes,
comparing measurements from both N2 and CB502 worms. We measured mRNA
expression of two different genes: ama-1, encoding a subunit of RNA polymerase
II, and arf-3, encoding an ADP ribosylation factor. Both genes have “housekeeping”
functions, so we predicted that their mRNA would scale with volume. We measured
concentration of these mRNAs by performing RNA FISH and counting spots as
usual, then normalizing to the volume of the imaged area, approximated simply by a
rectangular prism defined by the field of view. We found that the RNA concentrations
were roughly the same between the two strains, despite the smaller strain having
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Figure 2.10: RNA scales with volume in C. elegans. (A) Images of the two C. elegans
strains. Scale bars are 10µm. (B) Sizes of the two strains. (C) Number of mRNA
molecules per cell in the gonad region for each type of worm for genes ama-1 and
arf-3. We estimated the number of cells in each segment by counting nuclei stained
with DAPI. Each bar is a compilation of 3 biological replicates, with >3 worms per
replicate. (D) Concentration of mRNA in the gonad region. All error bars represent
standard error of the mean.
smaller cells overall (Fig. 2.10). It is difficult to distinguish single cells within an
intact organism, but we approximated the number of RNA per cell by normalizing
the total amount of RNA in a field of view by the number of nuclei in the same field.
As expected, the number of RNA per cell decreased by a factor similar to that of the
volume differences between the strains, verifying that our observations can hold in
vivo.
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2.4 Transcriptional activity, not mRNA degrada-
tion, scales globally with cellular volume
We have shown that larger cells have a proportionally higher number of mRNA
than smaller cells, even if they have the same absolute number of DNA molecules. To
maintain this proportionality, larger cells must either transcribe more mRNA from the
same number of DNA molecules or degrade those mRNA more slowly. Mathematically:
dm
dt
= µ(V )− δ0m (2.1)
or
dm
dt
= µ0 − δ(V )m, (2.2)
where m is the number of mRNA molecules, µ is the transcription rate, and δ is the
degradation rate. Assuming that only either µ or δ is volume-dependent, to achieve
the scaling that we observe, we likely have µ(V ) = µ0V or δ(V ) = δ0/V , although it is
possible that both production and degradation terms have some volume dependence
(see below). To distinguish between the two possibilities above, we determined the
rate of mRNA degradation in cells of different sizes. We treated cycling primary
fibroblast cells with actinomycin D, a drug that inhibits transcription by binding to
the transcription initiation complex and inhibiting elongation. We performed RNA
FISH on two populations of cells: one was untreated, and the other was treated with
100nM actinomycin D for four hours. Since the treated cells had no active transcription,
all observed mRNA dynamics were the result of degradation, and we assumed that
the data could be fit by the following functional form:
m(t, V ) = m0(V )e
−t/δ(V ). (2.3)
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Indeed, we observed exponential decay over the course of a few hours (Fig. 2.11).
Comparing the untreated to the treated cells, we used the fit line for the untreated
cells to determine m0(V ), and determined δ(V ) for every treated cell we measured. We
found that degradation rate did not change significantly in cells of different volumes
(Fig 2.11), and indeed the data was much better fit by the model in which δ(V ) = δ0
than by the model in which δ(V ) = δ0/V . We therefore have shown that that reduced
degradation is not responsible for the increased number of mRNA in larger cells.
We also performed a second analysis in which we fit the data from the transcrip-
tionally inhibited cells to a discriminatory model with a fitting parameter α:
m(t, V ) = m0(V )e
−tV α/δ0 . (2.4)
A value of α = 0 indicated that the data was best fit by a model in which
degradation rate (δ) was independent of volume. A value of α = 1 indicated that
the data was best fit by the model in which δ = δ0/V . An intermediate value of α
suggested the possibility that both µ and δ had some volume dependence. As expected
given our previous data, we found that, for these genes, the best-fit model had a value
of α that was within error of 0, therefore showing in a second way that degradation
happens in a volume-independent manner.
We next checked whether larger cells transcribe more than smaller cells (as observed
in bulk populations [19, 55, 79]). We inferred global transcription rate by incorporating
a labeled uridine into all newly synthesized RNA produced during a 60 minute time
window (Fig. 2.12), which we then rendered fluorescent via click chemistry [24].
Note that mRNA with the labeled uridine had a nuclear export defect, so most
of the labeled nascent mRNA was sequestered in the nucleus. Therefore, the total
intensity of fluorescence within the nucleus was proportional to the total amount of
30
●
●●
●
●●
●
●●
●
●
● ●
●
●
●
●
●
●
●
●● ●●●
●
●
●
0.0
0.5
1.0
1.5
2 4 6
Volume (picoliters)
m
R
N
A 
de
ca
y 
co
ns
ta
nt
●
●
●
● ●
●
●
●
●
●●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●●
●
●
●
●
●
●
●
0
500
1000
1500
0 2 4 6
Volume (picoliters)
U
BC
  m
R
N
A
Inhibit 
transcription
A
●
●
● ●
●
●
●
●
●
●
●
●●●
●
●
● ●
●
●
●
●●
●
●
●●
●
●● ●
●
●●
1
2
3
1 2 3 4 5
Volume (picoliters)
m
R
N
A 
de
ca
y 
co
ns
ta
nt
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●● ● ●● ●
●
●
●●
●
●● ●●
●
●
●
●● ● ●●
● ●●
●
●
●0
100
200
0 1 2 3 4 5
Volume (picoliters)
IER
2  
mR
NA
B
0.0
0.1
0.2
0.3
2.5 5.0 7.5 10.0
Volume (picoliters)
Fr
ac
tio
n 
of
 c
el
ls
Before inhibition
After inhibition
D
●
●
●
100
200
300
400
500
600
0 2 4 6
Time after Actinomycin D 
addition (hours)
M
ea
n 
U
BC
 m
R
N
A 
co
un
tC
RNA = 593.6207*e-t/4.2
Figure 2.11: Degradation rate is independent of volume. (A) and (B) We inhibited
transcription in primary fibroblast cells using actinomycin D for 4 hours and allowed
UBC (A) or IER2 (B) mRNA to degrade. Inset shows mRNA before and after
inhibition. Each point represents a single-cell measurement. We calculated the decay
constant for each cell using the best-fit line before inhibition (see Appendix A). Blue
line shows fit if degradation were volume-dependent; red line shows fit if transcription
were volume-dependent. Data represent one of two biological replicates. (C) RNA
degrades exponentially when transcription is inhibited with actinomycin D. Pictured
is UBC mRNA 0, 4, and 6 hours after transcription block. (D) Distribution of cell
volumes before and after inhibition by Actinomycin D. The volume distribution is
similar before and after we inhibit transcription. Although we cannot track a single
cell before and after inhibition, this suggests that actinomycin D likely does not change
the volume of a cell, so it is appropriate to use the fit line before inhibition to calculate
the decay constant. n = 459 cells before inhibition, 413 cells after inhibition.
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Figure 2.12: Transcription rate correlates with volume. (A) We fluorescently labeled
nascent RNA produced in one hour using the Click-iT eU assay in primary fibroblast
cells. Pictured is raw micrograph data. (B) We quantified the total fluorescence intensity
(transcription rate) by imaging the nuclei of single cells. Blue line shows fit for volume-
dependent degradation; red line shows fit for volume-dependent transcription. Data
shown is from quiescent cells, and is one of three biological replicates.
new transcription during the 60 minute time window. The total nuclear fluorescence
was therefore equivalent to the global transcription rate. We found that transcription
rate was linearly proportional to volume, thus showing that individual cells vary in
their overall transcription [13] and these variations correlate strongly with volume.
das Neves et al. [13] performed a similar transcription rate assay, and also found that
transcription rate was variable between cells, even suggesting that transcription rate
may depend on a small diffusible factor. However, the authors connected transcription
rate to the mitochondrial content of single cells, not cellular volume. It may be the
case that both volume and mitochondria play a role in regulating transcription. From
our data, however, we conclude that volume is linked to transcription rate and that
larger cells maintain proportionally higher levels of RNA by increased transcription
rather than decreased degradation as compared to smaller cells.
We also quantified fluorescence from probes targeting the internal transcribed
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spacer of the rRNA (the “intronic” sequence of rRNA) and showed that transcription
of rRNA scaled linearly with volume (Fig. 2.4), indicating that RNA polymerase I
transcription is also volume-dependent.
2.5 A global mechanism links transcription and
volume
The scaling of transcription with cellular volume could be due to (1) global factors
regulating transcription of all genes in a volume-correlated manner, or it could be
that (2) gene regulatory networks sense deviations in each particular gene’s protein
concentration and modulate transcription to restore concentration. In the latter case,
reducing protein concentration of any one gene would result in increased transcription
to compensate, whereas in the global scenario, reducing the concentration of any one
gene product would not appreciably affect the cellular volume, thus leaving the gene’s
transcription unchanged. We tested this by reducing the level of Lamin A/C mRNA
and protein in the cell via small interfering RNA (siRNA) (Fig. 2.13); we chose Lamin
A/C because its expression scales strongly with volume (Fig. 2.3) and is thought to
be tightly regulated [61].
To measure the transcriptional response, we took advantage of the fact that
transcription occurs in bursts [8, 12, 20, 47, 59, 69, 77]. Each gene on the DNA can
be in an “ON” or an ‘OFF” state, and only when a gene is ON does it produce RNA.
Different genes have different bursting kinetics, and we can define transcriptional
activity in terms of “burst size”—the number of RNA produced during a single ON
state—and “burst frequency”—how frequently the gene is in an ON state.
Genes that are actively undergoing a transcriptional burst have bright accumula-
tions of nascent RNA at the site of transcription itself [29, 30, 47, 77]. Note that because
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Figure 2.13: Transcription remains the same after protein knockdown. (A) We per-
formed siRNA treatment for 72 hours in primary fibroblast cells using either a control
siRNA (left), or an siRNA targeting LMNA mRNA (right). DAPI stain is shown in
purple, and LMNA mRNA FISH probe is shown in white. White arrows indicate
active transcription sites. (B) Quantification of cytoplasmic LMNA mRNA knock-
down by RNA FISH. Inset shows protein knockdown. (C) Comparison of the number
of LMNA transcription sites and transcription site intensity in siRNA control and
LMNA knockdown conditions. We detected transcription sites through intron/exon
colocalization using RNA FISH. All error bars represent standard error of the mean.
Data in B, C are a combination of two biological replicates, n = 323 cells for control
siRNA, 284 cells for LMNA siRNA.
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all of our measurements were in fixed cells, we could not observe genes bursting in time,
so we instead relied on population measurements, as opposed to time measurements.
Thus, in place of burst size, we measured the intensity of the accumulation of RNA at
the transcription site, and in place of burst frequency, we measured the number of
ON transcription sites in a single cell divided by the total number of DNA copies in
the cell (2 in G1, 4 in G2). We term this quantity “burst fraction” to differentiate it
from burst frequency. Burst fraction measures the total fraction of gene copies that
are ON at a given time, which is not precisely equivalent to the frequency at which a
single copy of the gene turns ON, but is nonetheless a measurement of how active the
gene is in time [29]. To ensure that we were identifying transcription sites correctly,
we labeled both the exons and the introns of our gene of interest, using two distinct
fluorophores. Introns are spliced out at the site of transcription, generally allowing for
precise detection of active transcription sites. We developed a graphical user interface
(GUI) that overlays images from the exon channel and intron channel, allowing the
user to manually select transcription sites. There are a few genes for which introns do
not appear to be immediately spliced out, but rather diffuse throughout the nucleus
still attached to the exons. Cases like this necessitate the manual identification of
transcription sites.
To reduce the amount of Lamin A/C protein in the cell, we used an siRNA, which
does not affect nuclear RNA [33]. We measured both the average number of active
transcription sites per cell and the intensity of those transcription sites, finding both
metrics unchanged upon reduction of Lamin A/C protein levels (Fig. 2.13). Because
we saw that transcription was unchanged even after the protein levels were reduced, we
concluded that increased mRNA counts in larger cells result from a global difference
in transcription rather than the activity of a particular gene network that regulates
the concentration of Lamin A/C. However, our data do not exclude the possibility
35
that there may be other situations in which mRNA levels are regulated by specific
networks.
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Chapter 3
How does it work? A mechanistic
view of the cell’s transcriptional
compensation for size and DNA
content
3.1 A diffusible trans factor sensing DNA content
and volume links cellular volume and tran-
scription
Thus far, we have established that there exists a strong correlation between cellular
volume and the amount of mRNA in the cell. However, we are interested in establishing
directionality of this correlation. It could be the case that either the total cellular
content exerts a global influence on transcription, thus making transcription scale with
cellular volume; or, alternatively, transcription itself may affect cellular volume. The
way to conclusively distinguish between these possibilities would be to add cellular
volume to a small cell and observe if and how transcription changes in response.
Unfortunately, there is no straightforward way to simply add volume to cells, so we
37
used an alternative method.
We made cell fusions (heterokaryons [46]) combining small human melanoma cells
expressing GFP mRNA (WM983b-GFP-NLS) with larger primary fibroblasts that did
not express GFP (Fig. 3.1). Note that the melanoma cells did not express the GAS6
gene, so we were able to identify heterokaryons as cells with two nuclei that expressed
both GFP and GAS6 mRNA. GFP mRNA in the melanoma cells exhibited a strong
correlation with cellular volume before fusion. Because only the smaller of the two cell
types expressed GFP, we could directly observe the influence of additional cell volume
on the transcription of a single gene. We found that absolute GFP mRNA counts
increased in fused cells as compared to the original small cells (Fig. 3.1), showing
that increasing total cellular content is by itself sufficient to increase absolute mRNA
abundance.
Moreover, the GFP mRNA counts scaled with heterokaryon volume (Fig. 3.2),
although with a different concentration than in the unfused cells, suggesting that
the rate of GFP transcription scaled with the ultimate volume of the fused cell.
The fact that the nucleus from the WM983b-GFP-NLS cell could change its overall
transcriptional activity showed that the modulation occured via the activity of a
diffusible trans-acting factor. The alternative is that transcription levels are hard-
coded into the DNA via some cis-acting factor. If this were the case, each nucleus
would continue producing RNA at the same levels as before fusion, and we would not
observe an increase in GFP mRNA upon fusion.
How might such a trans factor transmit volume information to the GFP gene in
order to increase its transcription concordantly with the increase in cellular volume?
There are two broad categories of mechanism: (1) The factor acts as a “volume sensor”
and does not know about the amount of DNA in the cell. An example could be a
modifiable global transcription factor protein whose degree of modification/activity is
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Figure 3.1: GFP mRNA is expressed at higher levels in fused cells. (A) Representative
image of fused cells (heterokaryon, left) and unfused cells (WM983b, primary fibroblast,
right). DAPI stain is in orange, GFP mRNA is in green, and GAS6 mRNA is in
white. White arrows indicate transcription sites. (B) Quantification of GFP mRNA in
unfused and fused cells. Box extends to first and third quartile, and whiskers extend
to the maximum-distance points within 1.5 inter-quartile ranges of the box. Data are
a combination of two biological replicates.
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Figure 3.2: GFP mRNA scales with volume in fused cells. GFP vs. volume for fused
and unfused cells. Upper dashed line represents best fit line by linear regression for
unfused cells. Lower dashed line is a model, not fit, and has a slope that is half of the
upper fit line.
proportional to cellular size (Fig. 3.3, left). The role of this factor is essentially to
communicate to the nucleus the size of the cell and have it produce RNA accordingly.
(2) The factor acts as a “volume/DNA sensor” whose activity depends on both
cellular volume and DNA content. One such mechanism is the existence of a general
transcription factor of limiting abundance relative to the number of binding sites in
the DNA (limiting factor, Fig. 3.3, right). We assume that the factor is expressed
proportional to cellular volume, so there is a higher absolute amount of factor in large
cells than in small cells. Here, the DNA “counts” how big the cell is by binding all
available factor molecules, thus increasing transcription in bigger cells as more factor
binds to DNA. Another possibility is the sequestration of such a factor to the nucleus,
which can also achieve the same volume/DNA sensing behavior if nuclear volume is
only weakly dependent on cellular volume. In this second case, the factor need not
be limiting relative DNA binding sites. We explain this model, and some interesting
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Figure 3.3: Models of transcriptional output in fused cells.
consequences thereof, in Section 3.3.
We distinguished between these two alternatives by comparing the concentration of
GFP mRNA in the fused and unfused cells (Fig. 3.2). In the volume sensor scenario,
the fusion cell would have the same concentration of GFP mRNA as the original
small cells because the factor transmits the volume information to the GFP gene
independent of the number of nuclei in the cell. We expect that transcription from
each nucleus would be the same as it would be if there were only a single nucleus in
the new, larger volume. While GFP mRNA would display the same concentration in
this scenario because the GFP gene is present in only one nucleus, we might expect
that genes present in both nuclei would have double the mRNA concentration, as both
nuclei would produce this mRNA to fill the volume without knowledge of the other
nucleus.
In the volume/DNA sensor scenario, the fusion cell would have half the concen-
tration of GFP mRNA because the factor senses both the increased volume and the
two nuclei. For example, a limiting factor would be diluted between the two nuclei
in the fused cell, and each nucleus would only produce half the mRNA as it would
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if it were the sole nucleus in a cell of that size. In this scenario, we expect GFP
mRNA concentration to be half, but the concentration of mRNA from genes present
in both nuclei (e.g. GAPDH ) to be the same as in unfused cells. We found that the
concentration of GFP mRNA in the fused cells was strictly less than and very close
to half the concentration in unfused cells. We conclude that the factor responsible
for increased transcription in smaller cells was not a volume sensor, but responded to
both the size and DNA content. These results suggest that perturbations that change
cell size will indirectly change global transcript counts per cell through this generic
mechanism.
3.2 Transcriptional burst size increases in larger
cells
We next sought to understand the mechanism by which the diffusible trans factor
described above affected transcription by further by examining the relationship between
volume and transcription of individual genes. mRNA is produced in bursts, marked by
bright accumulations of nascent mRNA at the site of transcription. We characterize
this bursting behavior through burst size (how much RNA is produced during a
single burst) and burst fraction (how often a gene is actively transcribing, which is
related to burst frequency [29]). Refer to Section 2.5 for a detailed explanation of
our measurements. To quantify burst size, we measured the intensity of transcription
sites for four genes in our fibroblast cells, and found higher intensity transcription
sites in larger cells (Fig. 3.4), indicating that the factor we have described works
by modulating transcriptional burst size. We note that transcriptional burst fraction
was similar in cells of all volumes (Fig. 3.7), so the main source of transcriptional
modulation across cells of different sizes results from a change in burst size. We further
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showed that transcriptional burst size does not change throughout the cell cycle (Fig.
3.4), showing that there is a direct link between transcriptional burst size and cellular
volume.
We hypothesize that this volume/DNA sensing trans factor, which may be either
a limiting factor or one that is simply sequestered to the nucleus (described in detail
in Section 3.3), has the following properties: (1) it is important for transcription,
(2) is is almost purely nuclear, and (3) the total amount of the factor is proportional
to the volume of the cell. The general transcriptional machinery, of which RNA
polymerase II is a key component, satisfies these requirements. We confirmed that
by reducing the amount of RNA polymerase II in the cell, we saw a reduction in
transcription site intensity. This intensity is proportional to burst size [29], although
we note that saturation may limit the dynamic range of this measurement [56]. We
treated primary fibroblast cells with 100nM triptolide, which targets RNA polymerase
II for degradation [3], reducing its levels (Fig. 3.5). After one hour, we saw a reduction
of bright transcription sites for two different genes, showing that transcription site
intensity depends directly on the amount of transcriptional machinery available. We
note that in both knockdown and control conditions, there are many transcription sites
with similar low intensities. We believe this intensity is representative of the production
of a single transcript, which should remain the same between the two conditions. By
reducing the amount of polymerase, we reduced the number of transcription sites
producing more than one transcript per burst. We further note that transcription
site fraction did not change significantly between the two conditions (Fig. 3.5),
demonstrating that changing the amount of transcriptional machinery changes only
burst size, not burst frequency.
The Churchman lab at Harvard performed a fractionation assay for us [37], showing
that RNA polymerase II is 94% nuclear (Fig. 3.6), further supporting the hypothesis
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Figure 3.4: Transcription site intensity increases with volume, but not cell cycle stage.
(A) Transcription site intensity and volume in primary fibroblast cells for genes UBC,
MYC, EEF2, and TUSC3. Each data point represents the mean transcription site
intensity per cell for a quartile of cells classified by volume or GAPDH. We detected
transcription sites through intron/exon colocalization using RNA FISH. We calculated
volume for EEF2 data using EEF2 as a guide, and volume for MYC data using
GAPDH. We use GAPDH mRNA count as a proxy for volume for UBC and TUSC3.
(B) Transcription site intensity and cell cycle stage in primary fibroblast cells. We
determined cell cycle stage by Cyclin A2 and the histone 1H4E mRNA counts (see
Appendix A and Fig. 2.5). For intensity measurements, data for UBC, MYC, and
EEF2 are from one of two biological replicates (EEF2 : n = 190, UBC : n = 202,
MYC : n = 103 transcription sites). Data for TUSC3 are combined from two biological
replicates (n = 255 transcription sites).
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Figure 3.5: Burst size, but not fraction, decreases upon reduction of RNA polymerase.
(A) Quantification of transcription site intensity before and after treatment with
100nM triptolide for one hour. P-value represents the probability of randomly finding
the distributions of bright transcription sites (values to the right of the black line)
in each condition. (B) Quantification of transcription site fraction (mean number of
transcription sites per cell, not gated for cell cycle) before and after treatment with
100nM triptolide for one hour.
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Figure 3.6: RNA polymerase is expressed proportional to volume and is almost entirely
nuclear. (A) Western blot analysis reveals that >99% of the C-terminal domain
hyper-phosphorylated form of RNA Polymerase II (IIO) is present in the chromatin
fraction. The hypo-phosphorylated form of Pol II (IIA) is captured in all cellular
fractions. We generated subcellular lysates from the same batch of primary fibroblast
cells and probed with the F-12 antibody (Santa Cruz Biotechnology) that is directed
against the N-terminal region of RPB1, the largest subunit of RNA polymerase II. We
adjusted sample volumes so that Western blot signals of the subcellular fractions are
comparable. (B) Quantification of RNA polymerase II mRNA (quantified by RNA
FISH) vs. cytoplasmic volume in A549 cells. Data shown is from a single biological
replicate.
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that the general transcription machinery could be the diffusible trans factor we have
been describing. Lastly, we performed RNA FISH on mRNA from the POLR2A gene,
which encodes the large subunit of RNA polymerase II (Fig. 3.6). We saw that POLR2A
mRNA scaled with volume, suggesting that polymerase is expressed proportional to
cellular volume. Interestingly, unlike the mRNA from many housekeeping genes, the
intercept term for POLR2A mRNA vs. volume is negative instead of positive, indicating
that the concentration of polymerase is actually slightly higher in larger cells than it
is in smaller cells. We do not fully understand why this is the case or how the cell
might produce polymerase in such a manner, but we believe it may be a way for the
cell to compensate for the reduction in concentration of nuclear proteins that comes
from having slightly larger nuclei in larger cells (see next section).
3.3 Model of diffusible trans factor for vol-
ume/DNA ratio sensing
Here, we outline a fairly generic model for how a diffusible trans factor may transmit
information on the ratio of volume to DNA to lead to increased transcription in larger
cells irrespective of DNA content. The primary assumptions are that the factor is
predominantly localized to the nucleus, the factor is required for mRNA transcription,
and the cellular concentration of the factor is roughly constant irrespective of cellular
volume (i.e., the total amount of factor is proportional to cellular volume). RNA
polymerase II holoenzyme satisfies these conditions, although we do not claim that
RNA polymerase II is the factor.
The model assumes binding of the factor to the DNA, and that only bound factor
can result in productive transcription. The goal of the model is to provide a basis for the
empirical finding that larger cells have increased transcription from the same absolute
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number of DNA molecules. Our model encompasses two broad categories of mechanism
that would lead to a perfectly linear scaling of transcription with cytoplasmic volume:
(1) The factor is sequestered entirely in the nucleus, and so if the nucleus doesn’t
change with cellular volume, the concentration of the factor in the nucleus will be
proportional to the total amount of factor. Thus, the factor will be proportionally more
bound to the DNA in a larger cell than a smaller cell, producing more transcription. (2)
The factor is a purely “limiting” factor in the sense that it has a very high affinity for
DNA and the number of binding sites exceeds the amount of factor. In this situation,
essentially all available factor will be bound to the DNA, and so for each gene, there
would be proportionally more transcription in larger cells because more factor would
be bound to DNA. These mechanisms are not necessarily mutually exclusive. The
model incorporates affinity and nuclear volume as parameters, and so encompasses
both of these potential mechanisms.
Briefly, the conclusion we derive from our model is that both scenarios pose viable
mechanisms for scaling transcription with cellular volume. That said, we overall mildly
favor scenario 1. Our data show that nuclear volume increases somewhat with nuclear
size, which the model predicts should lead to a slight decrease in transcription in larger
cells, and thus a higher concentration of mRNA in smaller cells, which is precisely what
we observe. Moreover, there is a rough quantitative agreement between the degree of
increased nuclear volume and the higher concentration of mRNA in smaller cells.
We begin with a few definitions. We use quantities within brackets to denote
concentration (molecules per volume) and quantities without brackets to denote
number of molecules per cell. For instance, factorfree is the number of free molecules of
the factor, while [factorfree] is the number of free molecules per unit volume. factorDNA
denotes the number of factor molecules instantaneously bound to DNA, factortotal is
the total amount of factor in the cell/nucleus, and DNA is the number of binding
48
sites on the DNA for the factor in the nucleus. KDNA is the binding affinity of the
factor for a particular gene. The cellular volume is given by V , and the nuclear volume
by Vnuclear. Thus, given our assumption of proportionality, we define pfactor to be a
constant such that factortotal = pfactorV .
The total factor is given by
factortotal = factorfree + factorDNA. (3.1)
Dividing by the nuclear volume, we arrive at a relationship between concentrations:
[factortotal] = [factorfree] + [factorDNA] . (3.2)
The binding affinity is defined via mass action as
KDNA =
[factorfree] [DNA]
[factorDNA]
, (3.3)
and may be different for different genes owing to promoters having different numbers
of binding sites for the factor or different binding affinities.
Thus, the total concentration of the machinery bound to DNA is
[factorDNA] =
([factorDNA]− [factortotal]) [DNA]
KDNA
. (3.4)
Solving for [factorDNA], we find:
[factorDNA] =
[factortotal] [DNA]
KDNA + [DNA]
. (3.5)
In the limiting case where KDNA = 0, we expect all of the factor to be bound to
DNA, and in that case, we find [factorDNA] = [factortotal], as expected.
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Relating concentrations to volumes yields
[factortotal] =
pfactorV
Vnucleus
, (3.6)
where pfactor is the proportionality constant defined earlier. Similarly,
[DNA] =
DNA
Vnucleus
. (3.7)
Hence,
[factorDNA] =
pfactor
V
Vnucleus
DNA
Vnucleus
KDNA +
DNA
Vnucleus
. (3.8)
Simplifying,
[factorDNA] =
(
1
Vnucleus
)
pfactor · V ·DNA
KDNA · Vnucleus + DNA
. (3.9)
Because [factorDNA] = factorDNA/Vnucleus, we can solve for the total amount of
transcriptional machinery bound to DNA:
factorDNA =
pfactor · V ·DNA
KDNA · Vnucleus + DNA
. (3.10)
In the limiting case KDNA = 0 here, we find that factorDNA is directly proportional
to volume, and equal to the total amount of factor in the nucleus irrespective of
nuclear volume. However, in the case where KDNA is not zero, then the volume of
the nucleus will result in deviations from perfect scaling of transcription with cellular
volume. Intuitively, if the volume of the nucleus increases somewhat in larger cells,
then the concentration of the factor and the DNA will decrease and hence the amount
of factor bound to DNA will be somewhat less than it would be otherwise. In that
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case, larger cells would have somewhat less transcription than would be expected in
the case of perfect scaling of transcription with cellular volume, which fits with our
experimentally observed volume-independent transcript abundance (i.e., decreased
mRNA concentration in larger cells). We also observed that nuclear volume is somewhat
greater in larger cells. Thus, it was possible, at least qualitatively, that the increase in
nuclear volume could explain the apparent decrease in mRNA concentration in larger
cells. We thus wanted to check whether there is a quantitative agreement between
our observed relationship between nuclear volume and cytoplasmic volume and the
increased mRNA concentration in smaller cells, which would establish the plausibility
of such a model.
As mentioned, our measurements show that nuclear area and cellular volume
positively correlate. Approximating nuclear volume by raising nuclear area to the 3/2
power, we find a linear relationship between nuclear “volume” and cellular volume
(Vnucleus ∝ a + bV ), with y-intercept a = 2169 fL (95% C.I. = (1923, 2381)fL), and
slope b = 0.9354 (95% C.I. = (0.8313, 1.042)). It is important to note that the while
the relationship is well fit by a line, the line does not pass through zero, and so
nuclear volume is not directly proportional to total cellular volume. Using this linear
relationship, we can express the total amount of factor bound to DNA as a function
of cellular volume:
factorDNA (V ) =
pfactor · V(
ã+ b̃V
)
+ 1
, (3.11)
where ã = KDNA
DNA
· a and b̃ = KDNA
DNA
· b. The ratio a/b (= ã/b̃) has units of volume, and
is geometrically equivalent to the x-intercept of the line of best fit between nuclear
volume and cellular volume.
We now wanted to check whether the volume-independent transcription we observed
in our mRNA-volume plots would quantitatively agree with this model. Because the
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factor is required for transcription and only transcribes when bound to DNA, then each
gene essentially grabs a fixed proportion of the amount of factor bound to DNA. (This
fraction will depend on the specific regulation of the gene.) So the total transcription of
a gene will be proportional to factorDNA. Thus, lumping together this proportionality
constant along with mRNA production and degradation and other associated constants
into a constant c, the relationship between RNA and volume is given by:
RNA(V ) = c · factorDNA (V ) . (3.12)
We should be able to fit our RNA vs. volume data using the above equation to obtain
estimates for ã and b̃, in particular their ratio, which is directly comparable to the
ratio a/b.
We did so for three genes and found fitting parameters:
UBC ZNF444 EEF2
ã (fL) 1.578 95.68 0.2747
95% C.I. (ã) (fL) (0.8524, 2.461) (70.23, 127.9) (-0.1518, 0.5630)
b̃ 1.936×10−4 0.01495 0.0003658
95% C.I. (b̃) (-7.617×10−5, 4.595×10−4) (0.004163, 0.02394) (0.0002680, 0.0005879)
ã/b̃ (fL) 7044 6446 744.4
95% C.I. (ã/b̃) (fL) (-62743, 111200) (2988, 28110) (-253.5, 2064)
For the fit of nuclear area to volume, we find the ratio a/b = 2329 fL, with a 95%
confidence interval of (1844, 2851) fL. We note that the ratios ã/b̃ for all of our genes
are of that same order of magnitude, albeit with large error. This result suggests that
the above equation for factorDNA (V ) may be the equation governing the production of
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mRNA in cells. This model provides an explanation that is quantitatively consistent
with our data for why smaller cells exhibit proportionally slightly more transcription
than larger cells—nuclei in small cells are slightly smaller than those in large cells,
increasing the concentration of factorDNA (V ), and therefore increasing transcription.
Our results are consistent with RNA polymerase II holoenzyme being the factor.
RNA polymerase II is required for transcription, transcribes when bound to DNA,
and is almost exclusively localized to the nucleus. Also, most reports indicate that
most RNA polymerase II in the nucleus is not specifically bound to DNA [9, 26, 27].
Based on that fact, one would expect that increased nuclear size should lead to slight
under-transcription, as we observed. Our analysis shows that this relationship is
quantitatively plausible. Further studies will be required to rigorously establish that
RNA polymerase II holoenzyme is the factor that connects volume/DNA ratio to
transcription.
We have shown that the RNA encoding the large subunit of RNA polymerase II is
expressed proportionally to volume, but with a negative intercept term, suggesting
that the concentration of RNA polymerase may be higher in larger cells. We do not
understand mechanistically how this might happen, but we suspect it may be a way
for larger cells to compensate for having larger nuclei. By producing more polymerase
in larger cells, larger cells will have a slight boost in transcription. Our observations
show that large cells do have a slightly lower concentration of RNA than smaller cells,
so the higher levels of polymerase are not a complete compensation, but still may be
a means of keeping concentrations more similar between large and small cells.
Note, however, that in many situations such as in early embryogenesis, nuclear
size does change dramatically as a function of cellular volume. In these situations,
the mechanism we describe would face a challenge because the concentration of RNA
polymerase II holoenzyme in the cell’s nucleus would remain the same after division
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(and the associated decrease in cellular volume), leading to over-transcription. The
limiting factor model (scenario 2, with KDNA very small) would not suffer from these
issues. It is possible that some intermediate scenario is at play in early embryogenesis.
Another problem with these models is the potential for runaway positive feedback,
in which a random increase in the factor would lead to more production of the
factor, thus leading to runaway transcription. For this reason, we expect that the cell
maintains strong control of factor levels to avoid these issues. Ultimately, a complete
understanding of factor dynamics will likely require adding growth to models of
transcriptional homeostasis.
3.4 A DNA-linked cis-acting factor reduces tran-
scription fraction, not burst size, immediately
after DNA replication
Thus far, we have discussed the means by which large cells and small cells produce
different amounts of mRNA from the same amount of DNA. However, cells have a
second challenge to overcome as well. We have shown that cells in the G1 and G2
phases of the cell cycle can have the same volume and same mRNA concentration
(Fig. 2.6), although cells in G2 have twice the number of DNA molecules as those
in G1. How then do two cells of the same size produce the same amount of mRNA,
despite having different amounts of DNA?
We previously found that transcriptional burst size scales with volume (Fig. 3.4),
so we now measured burst fraction. To measure transcriptional burst fraction, we
counted active transcription sites in each cell and divided by the total number of
gene copies for each stage of the cell cycle (two copies in G1, four copies in G2). For
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all of the genes we measured, the fraction per gene copy in G2 was approximately
half of that in G1 (Fig. 3.7). This is a very interesting result, as it shows that cells
can produce the same amount of mRNA before and after DNA replication by only
allowing each gene copy to transcribe with half the frequency after replication. We
note that this is not due to repression of replicated copies of DNA, as we observed
cells in G2 with four active transcription sites (Fig. 3.8). This showed that the cell
has a mechanism to precisely reduce transcription frequency in G2 to keep overall
transcription constant across the G1 and G2 phases of the cell cycle. Transcription
burst fraction did not change with volume (Fig. 3.7), and transcription burst size did
not change over the course of the cell cycle (Fig. 3.4), showing that this mechanism
is distinct from the volume-compensating mechanism described above.
We were surprised that the mechanism compensating for DNA differences over the
cell cycle was different from the one compensating for volume. In principle, limiting
factor models, as described above, that may be responsible for scaling transcription
with volume would also compensate for increased gene copy number due to DNA
replication. If the limiting factor was completely bound to DNA before and after DNA
replication, only half as much factor would be bound to each gene copy in G2 as in G1.
This could theoretically lead to a decrease in transcription frequency by half in G2,
although it would also predict a decrease in transcriptional burst size in G2, which
we do not observe (Fig. 3.7). Moreover, such models predict an inappropriate boost
in transcription for genes that replicate early in S phase. The limiting factor would
distribute itself over all the DNA, essentially “double counting” the small percentage
of genes that replicate considerably earlier than the majority of DNA (Fig. 3.9). If this
were the case, we would expect early replicating genes to have similar transcription
frequencies per gene copy in G1 and S phase, although each gene would be present in
four copies in S phase instead of two as in G1, essentially doubling the transcriptional
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Figure 3.7: A cis-acting factor decreases transcription frequency immediately upon
DNA replication. (A) Fraction of transcription sites by cell cycle stage in primary
fibroblast cells. We determined cell cycle stage by Cyclin A2 and Histone 1, H4E
mRNA counts. Dashed lines represent half the fraction of active transcription sites
in G1. We normalize all G1 data to two gene copies, and all G2 data to four gene
copies. For EEF2, MYC, and UBC (early replicators), we normalize S phase data
to four gene copies. For TUSC3 (late replicator), we normalize S phase data to two
gene copies. (B) Number of transcription sites per gene copy classified by volume in
primary fibroblast cells. Each data point represents the mean number of transcription
sites for a quartile of cells classified by volume. We calculated volume for EEF2 data
using EEF2 as a guide, and volume for MYC data using GAPDH. We use GAPDH
as a proxy for volume for UBC and TUSC3. For burst fraction measurements, data
for EEF2, UBC, and TUSC3 are a combination of two biological replicates (EEF2 : n
= 516, UBC : n = 332, TUSC3 : n = 255 transcription sites). Data for MYC is from
one of two biological replicates (MYC : n = 103 transcription sites).
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UBC mRNA
Figure 3.8: Replicated gene copies are transcriptionally competent. UBC mRNA in a
primary human fibroblast cell. RNA FISH probe in white, DAPI stain in purple. White
arrows indicate transcription sites. We detect transcription sites through intron/exon
colocalization by RNA FISH. This cell is in G2 and has four transcription sites,
demonstrating that all gene copies are transcriptionally competent after replication.
output between G1 and S phase.
To see if this was the case, we measured transcriptional burst fraction for early
replicating genes in S phase (EEF2, MYC, UBC ; see Fig. 3.10 for replication timing).
We classified cells as being in G1, S, or G2 based on cell cycle markers as described in
Fig. 2.5. These early replicating genes all showed the same transcription fraction per
gene copy in S and G2, implying that overall transcriptional output of these genes
remained the same throughout the cell cycle. This observation ruled out the possibility
that transcription fraction changes simply because a factor gets diluted between copies
of replicated DNA.
This leaves two alternatives for burst frequency reduction between G1 and G2:
(1) transcription frequency could universally decrease by a factor of two upon the
initiation of S phase, or (2) transcription frequency could decrease on a gene-by-gene
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Figure 3.9: Schematic of potential mechanisms for changing gene expression with cell
cycle.
basis (i.e., in cis) immediately upon DNA replication. We note that scenario 1 would
actually lead to the opposite problem of the one described above—genes that replicate
late in S phase would be under -transcribed for the majority of S phase. Because such
genes only have two copies for the majority of S phase, if frequency is reduced at the
beginning of S phase, these genes would have half the transcriptional output in S as
in G1.
To test between these alternatives, we imaged transcription of a gene that replicates
very late in S phase (TUSC3 ; Fig. 3.10). If transcription frequency were universally
reduced by a factor of two at the beginning of S phase, this gene would have the same
transcription fraction per gene copy in S and G2, despite having two gene copies in S
and four in G2. However, we found that this late-replicating gene maintains G1 levels
of transcription through S phase, and does not reduce transcription fraction until G2.
Therefore we conclude that there exists a mechanism whereby transcription frequency
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Figure 3.10: EEF2, MYC, and UBC genes are replicated early in the cell cycle; TUSC3
replicates late. Tracks from UCSC genome browser displaying UW Repli-Seq data in
GM12878 (lymphoblastoid), K562 (chronic myelogenous leukemia), HeLa (cervical
cancer), HepG2 (liver carcinoma), and HUVEC (human umbilical vein endothelial)
cell lines. The track displays data for different points in the cell cycle: G1, S1 (early S
phase), S2 (middle-early S phase), S3 (middle-late S phase), S4 (late S phase), and
G2. WS represents a wavelet-smoothed transform of the six other tracks. This data
was generated by sequencing newly-replicated DNA in each point in the cell cycle.
Darkness of track corresponds to read density.
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is reduced by a factor of two immediately upon replication of that gene, with different
timing for different genes. Candidates for such a mechanism include the partitioning
or modification of DNA-linked factors, such as histones with particular modifications,
upon DNA replication, resulting in half the transcriptional burst frequency as before
replication.
An interesting question is how this mechanism “resets” after a cell divides. After
cell division, each new daughter cell gets two of the four copies of DNA from the
mother cell. If nothing changed during division, each of the daughter cells would still
transcribe with the G2 frequencies, leading to an under-production of mRNA. To
overcome this, each cell must return to its original G1 transcription frequency between
M phase and the new G1 phase after division. It is likely that histones and basal
histone marks stay in place during M phase, although there is evidence for histone
acetylation and methylation occurring during M phase [68]. It could be that histone
modifications are added or removed during M phase to reset transcription frequency
back to an appropriate level. How transcription frequency is reset is an interesting
question, and one that remains open.
Together our data demonstrate the existence of two separate transcriptional mecha-
nisms that allow cells to maintain RNA concentration despite changes in DNA content
and cellular volume. Cells modulate transcriptional burst size through a trans mecha-
nism to allow larger cells to produce more mRNA from the same amount of DNA, and
modulate burst frequency over the cell cycle in cis to maintain RNA concentration
despite changes in DNA content.
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Chapter 4
But what about the rest of us?
Exploring noise in RNA expression
Our RNA FISH data revealed that while the expression of most genes was consistent
with a volume-dependent transcription rate, many genes showed strong variability
in transcript concentration from cell to cell (see Appendix B, note MYC, ICAM1,
ACTA2 ). There is a precedent for such variability in the literature, and indeed there
is an entire scientific field dedicated to the study of variability in gene expression
[31, 49, 51, 54].
Variability or “noise” in gene expression is typically defined by measuring levels
of individual RNAs or proteins in single cells, without taking extrinsic factors such
as volume into account. The typical noise measure is the coefficient of variation,
CV = σ/µ, which is simply the standard deviation of the levels of RNA or protein in
single cells from a population normalized to the mean value across the population.
Here we have shown that the size of a cell can greatly impact RNA production,
leading to six-fold or greater differences in RNA levels between single cells. The
coefficient of variation does not distinguish between variability from volume and
variability from other sources. We were interested in quantifying noise from sources
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Figure 4.1: Visual representation of volume-corrected noise measure. (A) TBCB mRNA
abundance and volume in primary fibroblast cells. Each point represents a single-
cell measurement by RNA FISH. Histogram indicates mRNA distribution. Arrow
indicates volume-corrected noise measure. Gray line is best linear fit. (B) TBCB
mRNA concentration vs. volume. These data are the same as in (A), but each is
normalized by volume. Histogram indicates distribution of mRNA concentration. Gray
line indicates average concentration. Data are from a combination of two biological
replicates.
other than volume. Our collaborator Abhyudai Singh, Assistant Professor of Electrical
and Computer Engineering at the University of Delaware, developed a metric to
quantify this variability, which we term the “volume-corrected noise measure” (Nm)
[5, 25, 60], which is in principle similar to the squared coefficient of variation of mRNA
concentration, but accounts for volume-independent transcription (Fig. 4.1). The
following section (Section 4.1) was written in its entirety by Abhyudai Singh.
4.1 Computing volume-corrected noise measure
from single-cell mRNA and volume measure-
ments
We define volume-corrected noise measure as the cell-to-cell expression variability
in mRNA levels that cannot be accounted for by cell-to-cell differences in volume.
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Throughout the section, we denote the variance of a random variable X by σ2X .
Let m and V be random variables denoting single-cell mRNA level and volume,
respectively. The expected number of mRNA transcripts in a cell given its volume V
is assumed to increase linearly with V , i.e.,
〈m|V 〉 = a+ bV =⇒ 〈m〉 = a+ b〈V 〉, (4.1)
where 〈.〉 represents the expected value, and a, b are gene-specific constants (related to
volume-independent and volume-correlated transcript abundance, respectively). From
(4.1), the covariance between m and V is given by
Cov(m,V ) = 〈mV 〉 − 〈m〉〈V 〉 = 〈(a+ bV )V 〉 − (a+ b〈V 〉)〈V 〉 = bσ2V . (4.2)
The extent of cell-to-cell variability in mRNA counts that can be accounted for by
volume is
σ2〈m|V 〉 = σ
2
a+bV = b
2σ2V , (4.3)
which using (4.2) can be written
σ2〈m|V 〉 = bCov(m,V ). (4.4)
Volume-corrected noise measure Nm is defined as
Nm :=
σ2m − σ2〈m|V 〉
〈m〉2
(4.5)
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is obtained as follows using (4.4)
Nm = CV 2m −
bCov(m,V )
〈m〉2
= CV 2m − S
Cov(m,V )
〈m〉〈V 〉
, (4.6)
where CV 2m represents the total variability in mRNA levels measured by its Coefficient
of Variation (CV ) squared and
S =
b〈V 〉
〈m〉
=
b〈V 〉
a+ b〈V 〉
. (4.7)
4.1.1 Noise measure in a two-state promoter model
Consider two alleles, where each allele transitions independently between active
and inactive states with rates kon and koff . We assume that the transcription rate from
the active state increases linearly with cell volume V . We first compute CV 2m (mRNA
coefficient of variation squared) for the case where transcription is independent of
volume, and then extend it to the volume dependent case.
Transcription rate independent of volume
Let the transcription rate from active state be km. Then, the steady-state first and
second-order moment of the mRNA level m is given by
〈m〉 = 2Gonkm
γm
, 〈m2〉 = 〈m〉+ γm(1−Gon)〈m〉
2
2(Gonγm + kon)
+ 〈m〉2, (4.8)
where
Gon =
kon
kon + koff
(4.9)
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is the fraction of time an allele is in the active state, and γm is the mRNA degradation
rate. Note that the factor of two in (4.8) arises due to the presence of two alleles. This
results in
CV 2m :=
〈m2〉 − 〈m〉2
〈m〉2
=
1
〈m〉
+
γm(1−Gon)
2(Gonγm + kon)
. (4.10)
Transcription rate dependent on volume
We assume km = a + bV , where volume V is a random variable with mean 〈V 〉
and variance σ2V . Based on (4.8),
〈m|V 〉 = 2Gon(a+ bV )
γm
, 〈m2|V 〉 = 〈m|V 〉+ γm(1−Gon)〈m|V 〉
2
2(Gonγm + kon)
+ 〈m|V 〉2. (4.11)
Unconditioning on the volume we obtain
〈m〉 = 2Gon(a+ b〈V 〉)
γm
(4.12a)
〈m2〉 = 〈m〉+ γm(1−Gon) 〈〈m|V 〉
2〉
2(Gonγm + kon)
+
〈
〈m|V 〉2
〉
. (4.12b)
Using (4.11)
〈
〈m|V 〉2
〉
=
〈(
2Gon(a+ bV )
γm
)2〉
= 〈m〉2(1 + S2CV 2V ), (4.13)
where the mean mRNA count 〈m〉 is given by (4.12a), S is given by (4.7) and CV 2V is
the volume CV 2. Substituting (4.13) in (4.12b)
〈m2〉 = γm(1−Gon)〈m〉
2(1 + S2CV 2V )
2(Gonγm + kon)
+ 〈m〉2(1 + S2CV 2V ) + 〈m〉. (4.14)
65
Above equation yields
CV 2m :=
〈m2〉 − 〈m〉2
〈m〉2
=
1
〈m〉
+
γm(1−Gon)(1 + S2CV 2V )
2(Gonγm + kon)
+ S2CV 2V . (4.15)
As expected, (4.15) reduces to (4.10) when CV 2V = 0. In (4.15), the first term repre-
sents Poissonian noise in mRNA levels due to random birth and death of individual
mRNA molecules. The second term is the noise contribution from stochastic promoter
switching. Variation in mRNA levels due to cell-to-cell differences in cell volume is
represented by the last term. Removing the last term, we obtain the noise measure as
Nm =
1
〈m〉
+
γm(1−Gon)(1 + S2CV 2V )
2(Gonγm + kon)
. (4.16)
4.1.2 Estimating promoter transition rates between active
and inactive states
Noise measures obtained from single-cell mRNA count and volume measurements
are used to estimate promoter transition rates kon and koff using (4.16). To correct
for measurement noise, we take into account a 15% error in mRNA counting. From
(4.9) and (4.16)
Gon =
kon
kon + koff
(4.17a)
Nm =
1
〈m〉
+
γm(1−Gon)(1 + S2CV 2V )
2(Gonγm + kon)
+ CV 2count, (4.17b)
where CV 2count = 0.15
2 = 0.0225 represents the mRNA counting error. In the above
equations, quantities Nm, S (defined in (4.7)), CV 2V (volume CV
2), 〈m〉, Gon are
computed from data for a given gene. Using mRNA half-life information from literature,
rates kon and koff can be estimated by solving (4.17). The average promoter dwell
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time in the active and inactive state is given by
Ton =
1
koff
, Toff =
1
kon
, (4.18)
respectively, and reported in Table I under the column “Ton, Toff from Nm”. Since
there may be other unaccounted sources of noise in gene expression, these dwell time
estimates should be considered an upper bound on their actual values.
We contrast the above estimates to the scenario where all the mRNA expression
variability is assumed to arises from transcriptional bursting. From (4.10), kon and
koff in that case would be estimated by solving
Gon =
kon
kon + koff
(4.19a)
CV 2m =
1
〈m〉
+
γm(1−Gon)
2(Gonγm + kon)
+ CV 2count. (4.19b)
Since CV 2m > Nm, dwell times obtained from (4.19) (see “Ton, Toff from CV
2
m” in
Table I) are significantly larger than those obtained from (4.17). For example, using
the GAPDH noise measure, we estimate Ton = 4.9 hours. However, if one ignores the
contribution of cell volume in driving intercellular variation in GAPDH mRNA, the
mean dwell time in the active state is obtained to be 13− 14 days (331 hours) from
(4.19).
4.2 Noise in RNA FISH measurements
We evaluated Nm for all of the genes we measured by RNA FISH. A standard
measure of gene expression noise is the coefficient of variation (CV , standard deviation
divided by mean), which only takes into account the spread and the mean of the
expression data. Using such a measurement, most of the genes we measured by RNA
67
Average promoter dwell-time (4.18) obtained from the noise measure (Eq. (4.17)) or
the total mRNA expression variability (Eq. (4.19)). mRNA half-lives and dwell times
are reported in hours.
Gene Gon CV
2
m Nm/CV
2
m mRNA Ton, Toff Ton, Toff
half-life from Nm from CV 2m
ACTN4 0.65 0.14 0.4 13 6.1, 3.3 40.5, 21.8
GAPDH 0.65 0.23 0.17 24 4.9, 2.6 331, 178
EEF2 0.75 0.18 0.17 16 3.2, 1.1 1443.6, 481.2
FTL 0.3 0.58 0.32 24 6.3, 14.6 45.4, 105.9
ICAM1 0.05 0.8 0.8 6.5 0.5, 9.7 0.8, 15.4
ACTA2 0.2 1.18 0.9 3 5.1, 20.3 7.9, 31.6
LUM 0.15 0.7 0.75 24 7.8, 44.3 12.7, 72.5
SUPTH5 0.3 0.12 0.58 10 0.45, 1.1 1.4, 3.3
FISH would be deemed “noisy”, or far from Poisson noise levels. We calculated CV 2
for mRNA counts as well as mRNA concentration (counts/volume) for many genes in
our fibroblast cell line. Both of these measures assign higher noise levels to genes than
the volume-corrected noise measure (Fig. 4.2). A Poisson process is the “least noisy”
random process, in which the time between events (here, the time between production
events of a single mRNA molecule) is exponentially distributed, and all events are
independent. Because mRNA production occurs in bursts, we expect noise levels to
be higher than Poisson, particularly if we are simply counting molecules and not
accounting for volume. If, however, we instead measure Nm for each of our RNA FISH
genes, we see that many of them display levels of variability near to or indistinguishable
from Poisson (Fig. 4.3) once we account for measurement error (upper bound of
around 15% [47]). Our measurement error represents how accurately we can detect
and count single mRNAs. We plotted Nm against both mean mRNA abundance and
mean mRNA half-life (Fig. 4.3, half-life values from [62]). Interestingly, Nm does not
appear to depend significantly on either abundance or half-life, suggesting that there
is no simple way to estimate noise measures of genes without actually measuring Nm.
Using RNA FISH, we were able to calculate noise measures for approximately
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Figure 4.2: Noise measure comparison. mRNA count CV 2, mRNA concentration CV 2,
and volume-corrected noise measure for cycling primary fibroblast cells. Inset shows
genes that exhibit higher cell-to-cell variability in RNA, and had values too high for
main axes. Generally, mRNA CV 2 is highest, followed by concentration CV 2 and
volume-corrected noise measure. Error bars represent 95% confidence intervals by
bootstrapping.
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Figure 4.3: Volume-corrected noise measure does not depend strongly on mRNA
abundance or half-life. (A) Volume-corrected noise measure values for different genes
in primary fibroblast cells. Each data point represents a collection of single-cell
measurements for one gene. The straight gray line represents the Poisson limit. The
curved gray line is the Poisson limit plus our experimental noise limit, a combination of
the Poisson limit and a 15% measurement error. Error bars represent 95% confidence
interval by bootstrapping. Data for each gene is a combination of at least two biological
replicates, with at least 30 cells per replicate. (B) We compared volume-corrected noise
measure and mRNA half-life. We obtained half-life values from [62]. Volume-corrected
noise measure and mRNA half-life. Each data point represents one gene. For each
gene, we have at least two biological replicates with at least 30 cells per replicate.
Error bars represent 95% confidence intervals, calculated by bootstrapping.
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30 genes, allowing us to see that different genes show different noise levels. However,
30 data points are insufficient to draw large-scale inferences about noise profiles of
various classes of genes, so we were interested in calculating variability genome-wide.
To quantify this variability for all genes in the genome, we performed single-cell RNA
sequencing [6, 21, 57] on human foreskin fibroblast cells, and calibrated the data such
that we were able to extract volume and mRNA counts for all genes in 44 different
single cells.
4.3 Calibration of single-cell sequencing data to
RNA FISH
We prepared single cells for RNA sequencing using the Fluidigm C1 Single-Cell
Auto Prep System, a microfluidic device that transfers single live cells into individual
wells, lyses each cell and performs first- and second-strand synthesis within the device.
After processing the RNA in the device, we extracted cDNA and prepared libraries for
RNA sequencing using the Nextera XT library preparation kit, and sequenced on an
Illumina NextSeq 500. In order to extract cell size and calibrate our RNA sequencing
data to our FISH data (Fig. 4.4), we added synthetic RNA from the External RNA
Controls Consortium (ERCCs [14]) at known concentrations to the C1 device along
with our live cells, and sequenced both genomic RNA and ERCC RNA simultaneously.
We aligned reads to the hg19 build of the human genome with annotation added for
the ERCC control RNA sequences using STAR [15], and extracted counts per gene
using HTSeq [1]. To calculate FPKM (fragments per kilobase per million fragments
mapped), we manually extracted the “maximum exon length”—the length of the union
of all annotated exons for each gene—and normalized the number of reads mapping
to each gene by that gene’s maximum exon length (divided by 1000) and the number
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Figure 4.4: Summary of single-cell RNA sequencing calibration.
of total reads mapped per sample (divided by 106).
We assumed that each well received an equal amount of the ERCC control RNA,
and estimated the total amount of RNA in each cell by comparing the number of
reads mapping to the transcriptome for each cell to the number of reads mapping
to the ERCC control RNA [36, 74]. We assumed that this ratio of (genomic reads :
ERCC reads) was an accurate relative measure of total RNA per cell. There were 21
cells that had an extremely low genomic:ERCC ratio, which we assumed to be due
to library preparation or sequencing artifacts, and we excluded these cells from our
analysis (Fig. 4.5).
In addition to allowing us to estimate total RNA content per cell, the ERCC control
RNAs give us an idea of a reliable FPKM cutoff—the FPKM value below which there
is no longer a linear relationship between FPKM and the actual amount of RNA in
the cell. The ERCC control RNAs are a mix of synthetic RNAs of different lengths
at various relative concentrations. We mapped FPKM to ERCC RNA concentration,
and found that below approximately 10 FPKM, FPKM was no longer predictive
of concentration (Fig. 4.6A). Therefore in our further analyses, we only examined
genomic RNAs with FPKM > 10 to ensure that the values we used were an accurate
representation of the abundance of that RNA in the cell.
We have observed through RNA FISH that GAPDH mRNA is highly abundant and
strongly correlated with cellular volume, and we therefore assumed GAPDH mRNA
to be proportional to the total amount of mRNA in the cell. From here, we found a
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Figure 4.5: We eliminated low-“volume” cells from our analysis. (A) “Count” vs.
“volume” for GAPDH from single-cell sequencing data. We define “volume” as the
ratio between genomic reads and ERCC reads for each cell. This quantity is more
representative of total RNA, which we know to be roughly proportional to volume,
although the relationship is not exactly proportional due to volume-independent
transcription (see Fig 2.9). We observed two clearly distinct classes of cells, those with
a volume range that matches what we see by imaging and RNA FISH and those that
have very low volumes. For unknown reasons, these cells ended up with a considerably
higher ratio of ERCC reads than genomic reads, and we eliminated them from our
subsequent analyses. (B) ERCC counts vs. genomic counts for the cells that we kept
and those we eliminated.
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Figure 4.6: Calibration of single-cell RNA sequencing data. (A) Mean FPKM and
known concentrations for each of the ERCC reference transcripts. Each point represents
a single ERCC transcript and is an average over all 96 samples. An FPKM of 10 is
our cutoff for “reliable” measurements. (B) Mean count as measured by RNA FISH
vs. mean FPKM from single-cell RNA sequencing. Each point represents a single gene
and is an average over 44 single cells for single-cell sequencing, and an average over at
least two biological replicates with at least 30 cells apiece for RNA FISH. Error bars
represent standard error of the mean. (C) Comparison of “total RNA” distributions
from single-cell sequencing and RNA FISH. We assume that total GAPDH mRNA
counts by RNA FISH are proportional to total RNA. For sequencing data, we use the
ratio of genomic reads to ERCC reads as a proxy for total RNA. We scaled this ratio
to have the same mean as the distribution of total RNA by RNA FISH. (D) Mapping
between total RNA count (here, total GAPDH mRNA in single cells) and volume, as
measured by RNA FISH. Each point represents a single cell. We use this mapping to
convert total RNA from sequencing experiments to actual volume. The red line is the
best fit, as computed by principle components analysis.
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linear relationship between “total RNA” and cellular volume (Fig. 4.6D). In using
a linear regression to find this relationship, the best fit line changes depending on
which variable is considered as the dependent variable. Instead of using ordinary least
squares, we used orthogonal regression, or total least squares, which uses principal
component analysis to find the direction of maximum variance in a given dataset. For
two variables that are linearly dependent, the first principal component picks out the
direction of a best fit line that is invariant to choice of dependent variable.
We normalized our genomic:ERCC “total RNA” measurements to have the same
mean as the distribution of total GAPDH mRNA found through RNA FISH, and
compared the two distributions (Fig 4.6C). The two distributions of “total RNA”
found through RNA FISH and sequencing were remarkably similar, and we therefore
used our relationship between “total RNA” and volume by RNA FISH to estimate
the volume of the individual cells that we sequenced.
From our RNA FISH data, we found a linear relationship between “total RNA”
(total GAPDH RNA) and volume, and we used this relationship to convert total RNA
to relative cellular volume for the cells we sequenced. We then used the correlation
between FPKM and RNA FISH counts for our gene panel (Fig. 4.6B) to provide
estimates of absolute RNA counts for all genes in individual cells. It is important to
note, however, that there is substantial variance in the relationship between FPKM and
FISH count, and that the relationship is nonlinear. The relationship between FPKM
and FISH count is best fit linearly on a log-log plot, leaving us with the following
nonlinear relationship:
FISHcount = 10(log(FPKM)−a)/b,
75
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Figure 4.7: Qualitative comparison of count vs. volume from RNA FISH and single-cell
RNA sequencing. Example low-Nm (GAPDH ) and high-Nm gene (MYC ).
where a and b are the intercept and slope of the best-fit line on the log-log plot.
Finally, by assigning volumes to each of the cells in our single-cell sequencing
experiments and estimating RNA abundance in terms of absolute counts instead of
FPKM, we reproduced our RNA vs. volume plots using RNA sequencing data (Fig.
4.7), and found that qualitative trends we observed by RNA FISH were also present in
the sequencing data. From this data, we calculated Nm for every gene in the genome
that had a mean FPKM of 10 or greater. We found that Nm calculated from our
single-cell RNA sequencing data was a good estimate of Nm calculated by RNA FISH
(Fig. 4.8).
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Figure 4.8: Comparison between Nm calculated from RNA FISH data and single-cell
RNA-seq data. Each point represents a single gene. Nm is calculated by bootstrapping;
error bars represent 95% confidence interval, calculated by bootstrapping.
4.4 Cell-type specific genes are noisier than
ubiquitously-expressed genes
Using our RNA FISH data, we quantified Nm for genes in both primary human
fibroblast cells and lung cancer cells. In comparing both Nm and RNA count in these
two cell types, we noticed that three of the four genes (ICAM1, LUM, ACTA2 ) with
the strongest degree of cell-type expression specificity were also the three genes with
the highest noise measure of all the genes in our study (Fig. 4.9). To see if this trend
held more generally, we used our single cell RNA-sequencing data to explore noise
measure across all genes.
We had bulk RNA sequencing data for our primary fibroblast cells as well as for
our lung cancer cell line. Comparing FPKM across the two cell lines, we classified
genes as being ubiquitously-expressed (FPKM values in both cell lines are within 2
FPKM of each other) or cell type-specific (FPKM value in one cell line is at least
five times greater than in the other) (Fig. 4.10). We also classified genes as having
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Figure 4.9: Abundance and Nm comparison in fibroblast and A549 cells. (A) Average
mRNA counts in cycling primary fibroblasts and A549 cells, calculated using RNA
FISH. Gray line indicates a 1:1 correspondence. Error bars represent standard error
of the mean. (B) Volume-corrected noise measure in cycling primary fibroblast and
A549 cells, calculated using RNA FISH. Gray line indicates a 1:1 correspondence. Nm
calculated by bootstrapping; error bars represent 95% confidence interval. Data for
each gene are a combination of at least two biological replicates, with at least 30 cells
per replicate.
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high or low noise measures, using the Nm values we calculated for all genes using our
calibrated single-cell RNA sequencing data. On average, genes with higher abundances
had lower noise measures, so we wanted to choose genes that had abnormally high or
low noise measures for a given abundance. To do this, we transformed our Nm values
such that the best-fit line between log(Nm) and log(FPKM) had a slope of zero. We
then considered genes with a log(transformed Nm) > 0.5 to be high noise genes and
genes with a log(transformed Nm) <-0.5 to be low noise genes (Fig. 4.10).
We selected genes with high or low noise measures and looked for enrichment in genes
exhibiting cell-type specific expression between human lung cancer cell and fibroblast
cell data. We found that the set of high noise measure genes contained a significantly
higher proportion of cell-type specific genes than low-noise genes (Fig. 4.11). Such
findings mirror those showing that more ubiquitously expressed “housekeeping” genes
typically exhibit lower levels of noise than other types of genes, although the notion
of cell-type specificity is more difficult to relate to studies performed in single-celled
organisms [2, 42, 63].
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Figure 4.10: Classification of noisy and cell type-specific genes. (A) Volume-corrected
noise measures from single-cell RNA sequencing data in primary fibroblast cells. Each
point represents one gene. We observe that higher abundance genes typically have
lower Nm values. Red line indicates best fit line. (B) The same data as in A, but
transformed to remove the abundance dependence from Nm. Red line here is the
transformed fit line from A. We use this transformed data to select abundance-matched
“low Nm” and “high Nm” genes using a cutoff of Nm=0.5 and Nm=-0.5, respectively.
We selected 307 high Nm genes and 257 low Nm genes. Note that these high Nm
genes actually have a higher mean abundance (FPKM=196.5) than the low Nm genes
(FPKM=55.4), thus showing that the observed differences in noise levels are not due
to the overall increase in noise in genes of low abundance. (C) FPKM measurements
from bulk RNA sequencing in primary fibroblast and A549 cells. Each point represents
one gene. We classified genes as “ubiquitously expressed” if they had >5 FPKM in
both cell types and differed by less than a factor of 2 in FPKM across the two cell
types. We considered genes “fibroblast specific” if they had >5 FPKM in fibroblasts
and their FPKM was greater than five times higher in fibroblasts that A549 cells.
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Figure 4.11: High noise genes are enriched for cell-type specific genes. Breakdown of
high- and low-noise genes into ubiquitously-expressed genes and genes that express in
a cell-type-dependent manner. See Fig. 4.10 for classification criteria.
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Chapter 5
Discussion
We have shown that, for many genes, RNA count correlates strongly with volume,
regardless of position in the cell cycle and the number of DNA copies in the cell.
Moreover, we have shown that the cell employs two separate global transcriptional
mechanisms to compensate for differences in volume and changes in DNA content to
maintain the concentration of RNA. We expect that such generic and global mechanisms
are necessary for the proper functioning and homeostasis of cells, as biological processes
rely on the concentration, not the absolute count, of biomolecules within the cell. This
is important in a number of biological contexts such as development and embryogenesis,
in which rapid cell divisions lead to an exponential decrease in individual cell volume,
but the organism must maintain the concentration of most proteins while still enabling
dynamic transcriptional programs to occur [41].
Cells compensate for changes in cellular volume by increasing transcriptional burst
size in larger cells. Essentially, the same gene in a larger cell produces more RNA
every time it turns ON than it would in a smaller cell. How might this happen on the
molecular level? We have shown that there is overall more transcriptional machinery in
larger cells than in smaller cells, and that the size of transcriptional bursts is reduced
when the amount of transcriptional machinery is reduced. We speculate, therefore,
that the factor linking volume and transcription is the RNA polymerase II holoenzyme
or another component of the general transcriptional machinery. Thus, it is likely
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that larger burst size is a result of a longer “polymerase train” more polymerases
simultaneously moving down the body of a gene, producing more mRNA in larger
cells. It could be the case that either (a) polymerases pile up at the promoter when
the gene is in an OFF state, and all traverse the length of the gene once it turns ON,
or (b) once a gene turns ON, diffusing polymerases interact with the promoter and the
transcription initiation complex, stochastically initiating transcription. Either scenario
would give us bigger transcriptional bursts in larger cells, simply because there is more
polymerase in the nuclei of larger cells. Other studies [34, 79] have speculated that the
RNA polymerase II holoenzyme may act as a limiting factor titrated by DNA, but
various studies [9, 26, 27] show that RNA polymerase II is only directly associated
with DNA for short periods of time. Thus, it is perhaps more likely that scenario (b)
holds, although we cannot rule out either possibility with our current data.
We found it striking that the volume compensation mechanism is distinct from
the one that compensates for changes in DNA content as the cell cycle progresses. We
found that the burst frequency appears to decrease upon DNA replication for each gene
rather than at a particular time in the cell cycle for all genes. One plausible explanation
for this feature being separate from the volume compensation mechanism is to ensure
proper transcriptional output regardless of whether a gene is replicated early or late
in S-phase, which can proceed for many hours. The molecular underpinnings of this
mechanism remain unclear, although our results demonstrate that it must be a factor
that remains bound to DNA and changes in character during DNA replication. A
likely candidate may be a DNA or histone modification that completely coats the
DNA during G1 but is diluted by a factor of two per DNA copy upon DNA replication
in S-phase. The cell faces the challenge of “resetting” transcription back to G1 levels
after cell division, and we suspect that the cell accomplishes this by modifying DNA
or histones during M phase [68].
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The two mechanisms described here allow RNA production to scale with volume,
helping to maintain the concentration of mRNA between cells. However, we have
shown that mRNA concentration is in fact not constant between cells for two different
reasons. First, there are many genes with very “noisy” mRNA expression, whose
mRNA does not exhibit any correlation with volume. Second, even genes whose RNA
expression is tightly correlated with volume display higher mRNA concentrations in
small cells than large cells, as a result of volume-independent transcription.
To the second point, for many genes, we observe significantly different mRNA
concentrations in the smallest and largest cells, sometimes by a factor of two or
more. Overall, concentration is less variable than mRNA count, but it is far from
constant. Why might this be the case? We observe that smaller cells have a higher
concentration of mRNA than larger cells, leading to a positive non-zero intercept for
the fit line between mRNA and volume. It may be that small cells produce higher
concentrations of RNA and protein as a catalyst for growth, although we do not have
sufficient data to test this hypothesis. Interestingly, we observe that overall, volume-
independent expression is lower in growth-arrested cells than in cycling cells, providing
more evidence that there may be a link between volume-indpendent transcription and
growth.
How, mechanistically, do smaller cells have a higher concentration of mRNA than
larger cells? In our model for the volume/DNA sensor that links transcription and
volume, a factor is expressed proportional to cellular volume, primarily localized to the
nucleus, and transcriptional activity is dependent on the concentration of the factor in
the nucleus. We observe that nuclear size increases slightly with cytoplasmic volume,
so the concentration of the factor in larger cells will be slightly less than it would be if
nuclear size were constant. This slight decrease in concentration in large cells may be
enough to account for the mRNA concentration differences we observe in large cells
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and small cells, although more experiments will be required to establish this model
completely. Regardless of the origin of the effect, it is clear that mRNA concentration
is typically higher in smaller cells. We do not yet have sufficient data to understand
the consequences of this effect, in particular on cell growth, nor how it may vary in
different cell types and contexts.
We have also observed that there are some genes whose RNA simply does not
correlate with volume (R2 ≈ 0), and we consider these genes “noisy”. Why might a
gene be noisy? Genes that are turned on in response to particular stimuli, such as
heat shock response genes and cell cycle-dependent genes will be less likely to scale
with volume in general. If some cells have received a stimulus while others have not,
we would not expect all cells to have consistent levels or concentrations of mRNA.
Interestingly, for some cell cycle-dependent genes, we observe two distinct fit lines
between mRNA count and volume when we gate for cell cycle. When the gene is OFF
or lowly expressed, it has one characteristic mRNA concentration, and when it is ON,
it has a different concentration. However, if we observe mRNA from that gene without
gating for cell cycle, the data look noisy. This is likely not the case for all noisy genes,
but an interesting observation nonetheless. With our single-cell RNA sequencing data,
we now have the ability to look at noise levels of genes genome-wide. Using this data,
we can potentially begin to make inferences about types of classes of genes that have
high noise levels, and perhaps begin to study what makes genes noisy in the first place.
An interesting question is how it is even possible for genes to be highly noisy, given
that there is a global transcriptional mechanism causing mRNA expression to scale with
volume. In this work, we showed that transcription of the LMNA gene is regulated
globally, not by a gene-specific network that senses LMNA protein concentration.
However, this is not to say that genes are not also subject to individual regulation
outside of the global regulation by cell volume. Rather, each gene has its own promoter
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and enhancer(s), and its transcription is activated by particular transcription factors.
These factors together help to determine traits such as the noise level and the average
mRNA expression level of a given gene. The global mechanisms described in this work
simply provide a means by which any such additional regulation may operate without
having to take into account differences in DNA concentration due to cellular volume
or DNA copy number differences. A consequence of this global mechanism is that
the RNA from any gene, noisy or not, should scale with volume in the mean. Larger
cells should have more mRNA than smaller cells, regardless of how variable the gene’s
expression is. Indeed, for all of the genes we measured by RNA FISH, we observe that
mRNA expression is higher in the largest 25% of cells than in the smallest 25% of
cells.
From our data, we conclude that transcription and volume are linked through a
factor that senses both volume and DNA content. We have strong evidence that this
factor is a part of the general transcriptional machinery, such as RNA polymerase II,
but we have not conclusively shown this to be the case. RNA polymerase fits all of
the criteria for the factor: it is expressed proportional to cellular volume, it is almost
entirely nuclear, and it is important for transcription. However, we cannot rule out
that there is another, more global factor that controls the expression levels of RNA
polymerase. Indeed, there must be some regulation on our factor, otherwise the model
as stated could lead to unregulated growth and the potential for enormous cells, which
we do not observe.
In our model, larger cells have more of the factor, which leads to more transcription
than in smaller cells. Similarly, because larger cells have higher levels of transcription,
they are able to produce more of the factor. At steady state, the model nicely describes
differences in size and transcription levels between large and small cells. However,
if the system is somehow perturbed, causing a cell to produce more of the factor
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than it should for its size, unrestricted growth could occur: more factor begets more
transcription, which causes cells to grow, and so on. It is possible that this problem is
simply solved by the fact that nuclear size scales with volume: perhaps as a cell grows,
its nucleus grows in size such that transcription rate does not continually increase
with volume. It is also possible that at some point, transcriptional activity can no
longer increase, even with more transcriptional machinery. There may be a point at
which DNA reaches its capacity, as there are only a finite number of binding sites
for transcriptional machinery. Both of these possibilities would lead to a plateau or
leveling-off of mRNA abundance above a certain volume. It is possible that we begin
to see such an effect in our heterokaryon data, and even in large datasets of GAPDH
mRNA in unperturbed cells. Zhurinsky and colleagues noticed this phenomenon in
large yeast cells [79].
It is important to note that throughout this work we have considered cells to
be static, and have not included growth in our models. It may be the case that we
need to consider growth in order to have a complete understanding of how cell size
and transcription are coupled. Perhaps there are independent regulators of growth
that indirectly affect transcriptional activity. Further, we have not addressed the
question of why cells have different volumes and how expression plays a role in that
heterogeneity—such questions necessarily involve the examination of mechanisms
regulating cell growth and proliferation. Rather, our results show how cells may
globally cope with such changes to maintain biomolecule concentration.
The work we report here highlights the importance of taking cellular volume into
account when interpreting gene expression data and points to the significance of global
factors in studying single cell expression in general [13, 16, 70]. In particular, our cell
fusion experiments show that changing the amount of cellular content in and of itself can
lead to changes in total RNA abundance, whereas previous experiments largely relied on
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cell-size mutants that make inferences of cause and effect more difficult [19, 39, 55, 79].
These cell fusion experiments directly establish that any perturbation that changes
cellular volume may result in global changes in overall transcript abundance as a
secondary rather than primary effect per the generic mechanism of a diffusible trans
factor that senses an increased ratio of volume to DNA. Thus, we believe one must take
care in interpreting experiments showing global changes in transcript abundance [32,
43], both from the perspective of establishing causal relationships, given that cellular
volume/content can by itself change transcription rates, and in the interpretation
of the functional significance, given that the concentration of many transcripts will
remain roughly the same despite these overall changes. An example of this is our
comparison of GAPDH mRNA levels in cycling and growth-arrested cells. Cycling
cells, on average, had more GAPDH mRNA molecules than the growth-arrested cells.
However, the concentration of GAPDH mRNA between the two types of cells was
approximately the same, due to the fact that growth arrested cells were smaller on
average than the cycling cells. Here, by simply counting mRNA, it would appear that
cycling cells are more active, when really the cells are just larger. Measuring mRNA
concentration instead of simply counting mRNA will resolve such interpretation issues.
On the one hand, we have shown that it is important to take volume into consider-
ation, and that mRNA concentration is a better metric in many ways than mRNA
count. However, we have also shown that mRNA concentration is not constant between
cells. One practical consequence of this finding is that the time-honored practice of
normalizing transcript data, be it qRT-PCR or RNA sequencing or RNA FISH, to
GAPDH mRNA abundance, while largely sound, does not fully account for differ-
ences in mRNA concentration between small and large cells. This suggests that new
strategies may be required for measuring cellular volume when interpreting PCR or
sequencing data, particularly in single cell RNA-sequencing experiments.
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Together, these findings provide a deeper quantitative understanding of single cell
gene expression and its role in maintaining cellular homeostasis. Further work may
elucidate how these homeostatic mechanisms for maintaining biomolecule concentration
manifest themselves in biological contexts and whether they are an important point of
dysregulation in disease processes.
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Appendix A
Experimental and computational
methods
Cell culture
We grew primary human foreskin fibroblast cells (CCD-1079Sk, ATCC CRL-
2097TM) and A549 cells (human lung carcinoma, A549, ATCC CCL-185TM) in Dul-
becco’s Modified Eagle Medium (DMEM) supplemented with 10% FBS and 50U/mL
penicillin and streptomycin (Pen/Strep). To create quiescent cells, we grew primary
fibroblast cells in DMEM with Pen/Strep, without FBS for seven days. We cultured
WM983b-GFP-NLS cells (WM983b is a human melanoma cell line from the lab of
Meenhard Herlyn) in Tu2% media (78% MCDB media, 20% Leibovitz’s L-15 media,
2% FBS, and 1.68 mM CaCl2). The WM983b-GFP-NLS contains EGFP fused to a
NLS driven by a cytomegalovirus promoter that we stably transfected into the parental
cell line. Before imaging, we plated cells on two-well Lab-Tek chambered coverglasses.
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RNA fluorescence in situ hybridization and imag-
ing
We performed single molecule RNA FISH on the samples as described previously
[18, 48, 49]. Briefly, we fixed the cells in formaldehyde or methanol, performed RNA
FISH using the specified pools of oligonucleotides, then washed and stained nuclei
with DAPI. We fixed most cells in this study using formaldehyde, but used methanol
for the experiments involving transcription site quantification because it resulted in
more accurate transcription site detection. We stained the actin cytoskeleton with
Phalloidin-Alexa 488 (Life Technologies) to detect cell boundaries.
We typically co-stained with sets of probes targeting many different mRNA. Typi-
cally, we used exon probes labeled in Alexa 594, introns with Cy3, Cyclin A2 with
Atto 647N (which labels cells in S, G2 and M phase [17]) and GAPDH with Atto
700. To distinguish cells in S phase from G2, we labeled Histone H4 mRNA with Atto
647N and Cyclin A2 mRNA with Atto 700 [53, 73].
We imaged the cells with a Nikon Ti-E equipped with appropriate filter sets. We
took a series of optical z -sections, each 0.2-0.35 microns high, that spanned the vertical
extent of the cell.
Image analysis and quantification
We manually identified cell boundaries and counted and localized RNA spots using
custom software written in MATLAB [48, 49]. We estimate the technical error in our
RNA count determination to be at most 15%.
To compute the volume of a cell, we detected the 3D positions of a highly abundant
mRNA by RNA FISH. We selected only the points that defined the outer boundary
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of the cell by examining each point and its neighbors within a 4µm radius. We kept
only the points that had a higher z -position than their neighbors (signifying the top
of the cell) or points that had no neighbors within 180 degrees (signifying the side
of the cell). Once we had the points, we interpolated the points to identify a smooth
representation of the cell surface. We repeated this in both an upward and downward
direction to identify the top and bottom of the cell. We calculated the volume of the
cell by summing the heights between the top and bottom.
Calculating the volume in this manner will always result in an underestimation of
the actual volume. To correct for this bias, we first computed the outline of the cell as
described above. We then dilated this hull, filled it with the same number of randomly
distributed points, and then repeated the algorithm on this new set of points. If this
volume matched that computed with the actual spots in the cell, we then computed
the volume by integrating between the top and bottom boundaries of the dilated hull.
We used GAPDH mRNA as the primary mRNA for our volume determinations,
but the volume computation did not depend on the number of spots identified nor
on the choice of volume-filling gene. We limited ourselves to the cytoplasmic volume
by removing a vertical cylinder corresponding to the nuclear outline. This procedure
does exclude the cytoplasmic volume above and below the nucleus, but that region
only comprised a very small proportion of the total cytoplasmic volume.
We identified transcription sites through intron/exon probe colocalization. We
manually annotated transcription sites by visually inspecting images of intron and
exon probes to determine instances of colocalized signal. To determine spot intensity,
we identified the z -plane of maximum intensity in a 0.375µm-square region around
the manually selected spot. We defined the intensity as the difference between this
maximum value and a background value. For the background value, we used the
median intensity in a 3.75µm-square annular region around the maximum intensity
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point. Note that transcription site intensity need not necessarily linearly relate to
transcriptional burst size [56].
RNA degradation
We measured RNA degradation by inhibiting transcription for four hours by
applying actinomycin D at 1µg/ml. We measured degradation of UBC and IER2
mRNA because they exhibited a strong correlation with volume while having a half-life
short enough to enable us to observe substantial degradation within four hours of
actinomycin D treatment while avoiding non-specific effects at longer times.
We used a model to determine whether degradation was volume-dependent (degra-
dation ∼ 1/V ) or volume-independent (degradation ∼ constant). We first fit the
untreated mRNA vs. volume data with a line having zero intercept. If degradation is
volume-independent, we expect the treated cells to also be well-fit by a line having
zero intercept, where the slope is determined by the untreated fit and an exponential
decay term:
m4h(V ) = s0V e
−γt,
where m4h is the mRNA count after 4 hours of treatment, s0 is the slope of the untreated
data (t=0), γ is the decay constant (degradation rate), and t is the treatment time.
Note that here γ is the only fit parameter and is independent of volume.
If degradation is volume-dependent, the equation becomes:
m4h(V ) = s0V e
−γt/V .
Here, γ/V is the decay constant (degradation rate), but γ itself is independent of
volume and is the fit parameter.
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The line and curve described by these equations are the fits to the raw data, and
the decay constants γ and γ/V are the fits we show to the calculated decay constants
that we show in Fig. 2.11.
We calculated the actual decay constant for each cell measured at the 4 hour
timepoint assuming exponential decay:
m4h(V ) = m0h(V )e
−γt,
where we approximate m0h = s0V , and γ could in principle be either volume-dependent
or -independent.
LMNA siRNA knockdown
We used an siRNA targeting LMNA (Cat. #: AM16708, ID: 40502) at 30nM and a
“scramble” control siRNA (Cat. #: AM4611) at 30nM. We incubated primary fibroblast
cells with the siRNA for 72 hours. We verified protein knockdown via Western blot,
using the SC-20680 (rabbit) antibody and a goat-anti-rabbit 680 RD secondary (Licor
926-68071).
Heterokaryon formation
We created heterokaryons by separately culturing primary fibroblast cells and
WM983b-GFP-NLS cells. Once the plates were 70-90% confluent, we trypsinized the
cells, resuspended them in DMEM Complete media, and combined half of each plate
of cells in a 15ml tube. We pelleted the cells and resuspended in PEG for 2 minutes.
We added media over the course of five minutes to allow cells to fuse, then plated
the cells onto two-well chambered coverglasses (Lab-Tek) and fixed the cells after 12
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hours.
We identified heterokaryons as cells with two nuclei that expressed both GFP
(WM983b-GFP-NLS only) and GAS6 mRNA (primary fibroblast) by RNA FISH. We
eliminated all homokaryons (two cells of one type fused together) from our analyses.
Fractionation and RNA polymerase II Western blot
This protocol was performed by the Churchman lab at Harvard. We performed cell
fractionation as described in [4] and based on [76] with modifications. We conducted
all subsequent steps on ice or at 4◦C and in the presence of 25 µM α-amanitin
(Sigma, A2263) and Protease inhibitors cOmplete (Roche, 11873580001) according
to manufacturer’s instructions. We pre-chilled all buffers on ice before use. We grew
primary fibroblast cells to a confluency of 90%. We removed media and washed plates
twice with 1x PBS before scraping cells into 1x PBS. We collected cells by centrifuging
at 500 g for 10 min. We gently resuspended the cell pellet corresponding to 1× 107
cells in 200 µl cytoplasmic lysis buffer (0.15% NP-40, 10 mM Tris-HCl pH 7.0, 150 mM
NaCl). We incubated the cell lysate for 5 min on ice, layered it onto 500 µl sucrose buffer
(10 mM Tris-HCl pH 7.0, 150 mM NaCl, 25% sucrose) and centrifuged at 16,000 g for 10
min. We carefully removed the supernatant (600 µl) corresponding to the cytoplasmic
fraction. We gently resuspended the nuclei pellet in 400 µl nuclei wash buffer (0.1%
Triton-X-100, 1 mM EDTA, in 1x PBS) and centrifuged it at 1,500 g for 1 min. We
removed the supernatant and gently resuspended the pellet in 200 µl glycerol buffer
(20 mM Tris-HCl pH 8.0, 75 mM NaCl, 0.5 mM EDTA, 50% glycerol, 0.85 mM DTT).
Next, we added 200 µl nuclei lysis buffer (1% NP-40, 20 mM Hepes pH 7.5, 300 mM
NaCl, 1M Urea, 0.2 mM EDTA, 1 mM DTT), vortexed, incubated on ice for 2 min and
centrifuged at 18,500 g for 2 min. We carefully removed the supernatant corresponding
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to the nucleoplasmic fraction (350 µl) and added 250 µl 1x PBS/Protease inhibitors
cOmplete to adjust the volume for Western blot experiments (described below). We
resuspended the chromatin pellet in 600 µl chromatin resuspension solution (25 µM
α-amanitin, Protease inhibitors cOmplete, in 1x PBS).
We monitored the success of cell fractionation by Western blot analyses. For Western
blot analyses, we probed membranes with the following primary antibodies: Pol II
(F-12, Santa Cruz Biotechnology; directed against the N-terminal region of Rpb1),
Pol II Ser2-P (3E10, Active Motif), Pol II Ser5-P (3E8, Active Motif), Histone 2B
(FL-126, Santa Cruz Biotechnology), U1 snRNP70 (C-18, Santa Cruz Biotechnology)
and GAPDH (6C5, Applied Biosystems). Next, we probed membranes with Cy5-
and Alexa Fluor 647-conjugated secondary antibodies (Cy5 goat anti-mouse, A10524;
Cy5 goat anti-rabbit, A10523; Cy5 goat anti-rat, A10525; Alexa Fluor 647 rabbit
anti-goat, A21446; Life Technologies), and scanned using a Typhoon 9400 scanner
(GE Healthcare). We quantified fluorescent signals with ImageJ 1.47v software.
Triptolide
We degraded RNA polymerase II in primary fibroblast cells by incubating cells in
100nM triptolide for one hour, then fixed cells in methanol (control cells remained
untreated).
Cell size verification
To check that fixation did not alter cell size, we monitored the size of cells through
the fixation and permeabilization process by fixing cells while on the microscope
stage. We monitored cell area by taking images in brightfield, and we monitored cell
height by coating the cells with fluorescent beads and imaging them in a series of
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optical z -sections. We took images of the same cells after 10 minutes of fixing in 4%
formaldehyde and after 30 minutes of permeabilization in 70% ethanol. We calculated
cell area by segmenting the cells as usual, and we determined height by identifying
the plane of the bottom of the cell and the plane of the top of the cell (the last plane
where beads remain motionless) and subtracting the two values.
Quantification of cell-to-cell variability
We developed a phenomenological metric for cell-to-cell variability that takes into
account both volume-correlated and volume-independent contributions to mRNA
numbers per cell (see Section 4.1 for derivation and further information). We also
used a model of transcriptional bursting with volume-dependent transcription that
enabled us to quantify transcriptional parameters from population distributions of
mRNA counts and volumes.
Repli-seq analysis
We accessed Repli-seq data from Hansen et al. [22] using the UW Repli-seq track
on the UCSC Genome Browser.
Bulk RNA Sequencing
We sequenced total RNA from primary fibroblast cells. We used the NEB Next
Ultimate Library Preparation Kit for Illumina and the Ribo-Zero Magnetic Gold
Kit. We used 50b paired-end reads and sequenced each of two replicates at a depth
of 10-15M reads. We aligned reads to hg19 using STAR’s included annotation [15].
We quantified reads per gene using HTSeq [1] and a RefSeq hg19 annotation. We
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calculated FPKM for each gene using R. All sequencing data is available at GEO
accession number GSE66053.
Single-cell RNA Sequencing
We isolated 96 single cells, lysed, and performed first- and second-strand synthesis on
a Fluidigm C1 Single-Cell Auto Prep System using a large size chip. We spiked in ERCC
(External RNA Controls Consortium) RNA controls, Mix 1 (Ambion 4456740) at a
concentration of 1:10,000 before adding the cells to the C1. We prepared cDNA libraries
using the Nextera XT DNA Sample Preparation Kit (Illumina, PN FC-131-1096) and
used 96 paired barcodes from the Nextera XT DNA Sample Preparation Index Kit (96
Indices, 385 Samples) (Illumina, PN FC-131-1002) following the abbreviated Fluidigm
protocol for the Nextera XT kit. We sequenced the samples on a NextSeq 500 using
75b paired-end reads to a depth of ∼1-2M reads per sample. To quantify sequencing
data, we aligned reads to hg19 (using STAR’s included annotation) and the ERCC
reference transcripts. We quantified reads per gene using HTSeq and a RefSeq hg19
annotation. All sequencing data is available at GEO accession number GSE66053.
Single-cell RNA Sequencing Calibration and
Analysis
We independently calculated ERCC and genomic FPKM for each sample, normal-
izing to the total number of reads mapped to ERCC loci or genomic loci, respectively.
All FPKM data shown for endogenous genes is this genomic FPKM. For each cell, we
considered the ratio of total genomic reads to total ERCC reads to be proportional to
the total starting amount of mRNA in that cell.
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We sequenced 96 wells total, of which 5 were “control” wells that contained no
cells and 14 were wells containing fixed cells. We excluded these 19 cells from the
analysis. Further, we excluded 12 cells that had fewer than 1 million total reads, and
21 cells that had a genomic/ERCC read ratio of less than 30. We performed all further
analyses on the 44 remaining cells.
Transform read ratio to volume
We assumed that the ratio of genomic/ERCC reads for each sample was proportional
to the total mRNA in each cell. We also assumed that, for our RNA FISH measurements,
total GAPDH mRNA counts were proportional to the total amount of mRNA in each
cell. The distributions for total mRNA obtained in this manner were similar between
RNA FISH and single-cell RNA sequencing, but had different means. We therefore
normalized the sequencing data to have the same mean as the RNA FISH distribution.
From our RNA FISH dataset, we have many co-measurements of GAPDH mRNA
(total mRNA) and volume from which we establish a transformation equation between
total mRNA and volume. We obtained this transformation equation using PCA, or
orthogonal regression. Using this equation, we transformed total mRNA obtained
through sequencing into actual volume in picoliters.
Transform FPKM to molecule count
FPKM is more a measure of mRNA concentration than mRNA count, as it is
normalized to total reads. To get a measure more similar to mRNA count, for each cell,
we multiplied each gene’s FPKM by the genomic/ERCC count ratio (“volume”) of the
cell. For each gene in our RNA FISH dataset, we fit the log of the seq “counts” and
the log of the actual counts from RNA FISH by orthogonal regression. We then used
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this transform to convert the FPKM of all genes to their RNA FISH count equivalent.
Note that, because we fit in log space, the transform between FPKM and count is
nonlinear, and actually scales as approximately FPKM ∼ (RNA FISH)1.7.
Once we had our single-cell sequencing data in terms of RNA FISH count and
volume in picoliters, we calculated Nm as described for RNA FISH. We performed all
of our sequencing analysis in R.
C. elegans growth and imaging
We grew N2 (wild type) and CB502 (sma-2 mutant) C. elegans on NGM agar
plates with OP50 lawns, kept at 20◦ C. Every 2-3 days, we transferred a small portion
of each strain to new plates to prevent overgrowth.
We released the worms off of the plates using phosphate buffered saline (PBS)
solution, then fixed with 4% formaldehyde for 45 minutes. We permeabilized and stored
the worms in 70% ethanol. We performed the RNA FISH protocol, then mounted the
sample between a slide and coverglass before imaging.
We manually identified head and gonad boundaries and counted and localized
RNA spots using custom software written in MATLAB.
To compute the volume of each worm segment, we multiplied the area of the
segment by the height of the segment (thus approximating the segment as a prism).
We determined the height by taking the vertical difference between the highest and
lowest RNA spots’ positions, as determined by our software. We determined the
number of cells in each segment through manually counting the DAPI-stained nuclei.
We obtained data from multiple segments. When combining the data (number of
mRNA spots per volume or per nucleus), we weighted each segment by its volume.
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Appendix B
Comprehensive RNA counts and
concentrations for all genes and
cell types
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Figure B.1: Count (A) and concentration (B) of all mRNA in cycling primary human
fibroblast cells. Each data point is an individual single cell measurement. In count
plots, red line indicates best linear fit to the data. In concentration plots, red line
indicates mean mRNA concentration. Each data set is a combination of at least two
biological replicates.
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Figure B.2: Count (A) and concentration (B) of all mRNA in quiescent primary human
fibroblast cells. Each data point is an individual single cell measurement. In count
plots, red line indicates best linear fit to the data. In concentration plots, red line
indicates mean mRNA concentration. Each data set is a combination of at least two
biological replicates.
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Figure B.3: Count (A) and concentration (B) of all mRNA in A549 cells. Each data
point is an individual single cell measurement. In count plots, red line indicates
best linear fit to the data. In concentration plots, red line indicates mean mRNA
concentration. Each data set is a combination of at least two biological replicates.
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